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Chapter 1                                                                              General introduction 
1.1 Drug abuse and addiction 
 
Drug addiction is regarded as an irresistable compulsion to take a drug with 
loss of control over drug intake and is a chronic relapsing disorder. The 
American Psychiatric Association (APA) defined “substance dependence” as 
a syndrome equivalent to addiction and thereby classified it as a severe 
mental disorder1. The Diagnostic and Statistical manual of Mental Disorders-
VI (DSM-IV) states that at least three of the following seven criteria should 
be present in a person at any time in the same 12-month period in order to 
diagnose this person as addicted: (1) tolerance, (2) physical dependence, (3) 
preoccupation with obtaining the drug, (4) use in spite of adverse physical or 
psychological consequences, (5) giving up of social and recreational 
activities, (6) persistent desire and unsuccessful attempts to quit and (7) use 
of the drug in larger quantities and for longer periods of time than intended.  
Although addiction is recognised as a disorder by most clinicians and 
scientists, the general public tends to ascribe drug addiction to a lack of self-
control and weak character. The use, misuse, abuse of and dependence on 
(illicit) drugs continues to have negative implications on our society, such as 
causing medical, social, judicial and political problems, although only a 
small population of the public has developed a severe addiction. For 
instance, in the age groups 15-64 years only 1.1% of the Dutch population 
uses cocaine on a regular basis and 0.6% uses amphetamines on a regular 
basis. Tobacco and alcohol are more widely used, but these drugs have the 
reputation of having a less severe impact on daily functioning and are more 
socially accepted. However, for alcohol, there is a clear distinction between 
social drinking and true alcoholism, the latter causing severe impact on 
functioning of the user. 
A question that has kept scientists and clinicians busy for a long time is why 
some people actually become addicted while others do not. It is difficult to 
establish exactly how many people are “addicted” to drugs. However, it has 
been shown that whereas 3.6% of the Dutch population reported to have ever 
used cocaine, only 1.1% reports to have used cocaine recently. This implies 
that approximately 30% of the people coming into contact with cocaine 
actually become regular users or addicts (for more information, see 
http://www.trimbos.nl). 
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1.1.1. Theories of addiction 
Two main theories concerning the development of drug addiction have been 
postulated, being the exposure theory and the adaptive theory11,181. The 
exposure theory states that exposure to the drug itself is the critical factor for 
developing subsequent addiction. This theory implies that all individuals are 
at risk for developing addiction. A consequence of this line of reasoning 
means that the most vulnerable individuals are those whose environment 
provides them with the opportunity to acquire the drug. In this view, 
repeated use of the drug is the cause of drug addiction, since this repeated 
use induces a drug dependence. If this theory were true, the only way to 
prevent drug addiction would be the removal of drugs from our environment 
by, for example, severely prosecuting drug possession and sale. However, 
this strategy does not seem to be very successful, judging from the use of 
cannabis in the USA, where its possession and sale is indeed severely 
prosecuted. Despite that fact, cannabis use is even higher in the USA  (11%) 
than in the Netherlands (6%) (http://www.trimbos.nl), where its possession 
and sale (in small quantities) is not prosecuted. 
The second theory, the adaptive theory, states that individual differences 
prior to drug use determine whether an individual becomes addicted upon 
exposure to the drug11. This theory seems to hold true, because not all 
individuals that have used drugs once become addicted (see above). Surely, 
these two theories are not mutually exclusive, and a combination of both 
theories presumably posits a more accurate view on the development of 
addiction. Because not all individuals have a similar predisposition to 
become addicted, it is of critical importance to identify the factors that are 
involved in developing this predisposition. This identification might make it 
possible to develop strategies that can prevent addiction. These prevention 
strategies are possibly the only way to solve the addiction problem in 
society, because addiction is a very persistent disorder, causing irreversible 
changes in the brain, and patients are highly susceptible to relapse in spite of 
treatment.  
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1.1.2. Factors contributing to the development of addiction 
The aetiology of psychiatric disorders, among which addiction, is certainly 
not clear yet. However, it seems that genetic, early and late environmental 
factors all contribute to the onset of these disorders86. The interaction 
between all these factors has been postulated as the three-hit-model for the 
development of psychiatric disorders80,86. The contribution of these factors in 
the aetiology of addiction will be discussed below. 
 
1.1.2.1  Genetic factors 
Family studies 
Studies of family history and twin studies have all contributed to our current 
knowledge that a genetic component is certainly present in addiction. Family 
studies have indicated that substance abuse is increased in relatives of 
addicts152,163,164,200. These concordant family studies support a clear genetic 
vulnerability for drug abuse, but cannot separate familial environment from 
genetic factors. 
Twin studies 
Twin studies, especially those conducted on monozygotic twins, have shown 
that the heritability for drug abuse varies from 35% to 80%102,127,128,184. 
These studies clearly indicate a genetic component in substance abuse and 
genetic components appear to be more prominent in the more severe abusers 
and in some categories of drugs like heroin.  
 Adoption studies 
Adoption studies also contribute to the notion that a genetic component is 
present in drug addiction. Cadoret et al. studied adoptees that had been 
separated at birth from their biological parents. There was a significant 
correlation between drug disorder in the adoptee and alcohol problems in the 
biological parent, a correlation that was not present when the adoptive parent 
drank32-34.  
 Molecular genetic studies 
Although all previously mentioned clinical studies clearly indicate a genetic 
component in drug abuse, a clear genetic deficit would shed more light on 
the genetics of addiction. Molecular studies have focussed on the 
dopaminergic system and reported several positive associations between 
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drug abuse and polymorphisms of dopamine receptor genes (i.e. the DRD1, 
DRD2, DRD3 and DRD4). 
For instance, a significant increase in the frequency of homozygosity for the 
restriction polymorphism Dde 1 of DRD1 has been observed in subjects with 
drug use or other addictive behaviours such as gambling and compulsive 
eating47.  
Several studies have shown an association between drug abuse and the 
presence of the A1 allele of the DRD2 Taq1 polymorphism48,174-176,211. 
However, these data are not always replicated by others17,96. The differential 
results in these studies might well be explained by gene-environment 
interactions, as described by Madrid et al.154 (see also below).  
Studies have also been conducted on the association between homozygosity 
at the DRD3 Bal 1 polymorphism and cocaine and heroin addiction, but 
these studies have not shown a positive association94,137 
Associations with the 7-repeat allele of the DRD4 exonic polymorphism and 
opioid and heroin dependence have been shown138,145. Interestingly, an 
association has also been found with the personality trait novelty-seeking, 
which has been related to drug addiction13,77. 
Apart from association studies between the dopamine receptor genes and 
addiction, studies are also focussing on other genetic components, such as 
the tryptophan 2,3-dioxygenase gene (for the rate-limiting enzyme in 
serotonin biosynthesis)46, the short allele of the serotonin transporter gene205, 
the microsatellite polymorphism at the cannabinoid (CB1) receptor gene49 
and polymorphisms of the delta- and mu-opioid receptors50,159.  
The advances in molecular biologic research in the last years will surely 
keep contributing to our understanding of the genetic components in 
addiction. 
 
1.1.2.2.  Early life events 
The twin, family and adoption studies mentioned above clearly show that the 
genetic component alone is not sufficient to cause addiction. Concordance 
studies in monozygotic twins never reach 100%, which is a clear indicator 
that not only the genetic component is of importance. Human 
epidemiological studies on this subject are not abundant, but some papers 
did report an increased risk for addiction in individuals who suffered 
 11
Chapter 1                                                                              General introduction 
childhood abuse156. Also, parental separation increased the risk for 
alcoholism129. Finally, some studies have shown increased risk for 
developing addiction in individuals who, during their childhood, have been 
exposed to neglect (either emotional or physical) and a dysfunctioning 
household76.   
 
1.1.2.3. Late environmental factors 
It is well accepted that late environmental factors such as exposure to 
stressful events can also increase the risk for developing addiction. However, 
almost no (clinical) studies have been conducted on this subject so far. 
Recently, Madrid et al. published a study in which they clearly show that the 
occurrence of alcohol addiction is not associated with just the polymorphism 
of the Taq1 allele of the DRD2 receptor alone and also not by stressful 
events alone, but rather by an interaction between this genetic factor and 
stressful events (i.e. low socio-economical status)154. 
 
1.1.3. Towards an animal model for individual differences in the 
vulnerability to become addicted 
As discussed above, not all individuals that have been exposed to a drug 
become addicted and it is important to understand the underlying 
mechanisms that make an individual predisposed to drug addiction. 
Although human epidemiological studies can provide us with invaluable 
information, these studies do have their limitations. Single factors 
contributing to the aetiology of a disorder in a controlled environment cannot 
be studied in humans. Therefore, it is important to have an animal model in 
which the effect of single manipulations can be investigated on the 
behaviour and neurobiology of the individuals. It is also important to have an 
animal model in which the factors (i.e. genetic, early and late environmental) 
contributing to the aetiology of addiction  can be investigated.  
Rats can be used very efficiently as an animal model, because rats can learn 
to readily self-administer drugs with addictive properties. In the next section, 
an overview will be given of the available rat models for studying individual 
differences in the vulnerability for addiction with their possibilities and 
limitations. The common (neurobiological) factors of these models will also 
be discussed. 
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1.2. Animal models for individual differences  
Several animal models have been developed for studying individual 
differences in the vulnerability to become addicted. All these models use 
different methods to label their rats as individuals with a higher or lower 
predisposition to “become addicted”. Animals are either selected from a 
normal population of rats (for example the High Responder/Low Responder 
and the High Grooming/Low Grooming models), or selected based on the 
rats initial response to a drug (for example the High Cocaine 
Responders/Low Cocaine Responders), or bred for a certain characteristic 
(Alcohol Preferring/Alcohol Non Preferring and the Apomorphine-
susceptibe/Apomorphine-unsusceptible models). Although many more 
animal models for individual differences exist (for example genetically 
modified mice strains and inbred rat strains), discussing all these models is 
beyond the scope of this thesis.  
 
1.2.1. Animals selected on the basis of response to an 
environmental challenge 
1.2.1.1. High Responder/Low Responder model 
The most widely studied animal model in this category is the High 
Responder (HR)/Low Responder (LR) rat model. In this model, rats are 
selected from a normal population on the basis of their locomotor response 
to novelty when placed on an open field. Animals are labelled HR when 
their locomotor response is above the median of the average locomotor 
activity of the group and LR when their locomotor activity is below the 
median179,181. However, this selection method means that locomotor activity 
is not constant for HR versus LR, since the average locomotor activity of a 
group might differ between experiments. Therefore, the Nijmegen HR and 
LR rats are selected based on a fixed distance that the animals travel, in 
combination with a fixed habituation time (i.e. the time elapsed before an 
animal sits without moving for at least 90 seconds)54. In this case, HR rats 
are classified as animals that travel at least 6000 cm in 30 min and have a 
habituation time higher than 840 seconds, whereas LR rats are classified as 
rats that travel no more than 4800 cm in 30 min and have a habituation time 
lower than 480 sec54. Another important difference between the HR/LR rat 
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models in Nijmegen versus the models used by other laboratories is the 
actual open field that has been used. Whereas Piazza et al., Kabbaj et al., 
Hooks et al. and others use a circular open field with walls surrounding the 
open field, Cools et al. use a square open field with larger dimensions 
without walls surrounding the open field54,123,179. While keeping in mind the 
different selection procedures, there are many factors that characterize HR 
and LR rats in a similar way across all laboratories.  
Piazza and co-workers were the first to demonstrate that the response to 
novelty was highly correlated with, and could even predict, the capacity of 
the animal to acquire self-administration of psychostimulant drugs179. While 
HR rats readily developed low dose amphetamine self-administration, LR 
rats did not or to a much lesser extent179. In addition, HR rats are more 
responsive to acute administration of amphetamine and cocaine than LR rats 
and exhibit a higher sensitivity to the reinforcing properties of food111-113. 
Behavioural sensitization to repeated psychostimulant administration was 
also stronger in HR than in LR rats112.  
Interestingly, and seemingly in contradiction with the amphetamine self-
administration studies of Piazza, the Nijmegen HR appears to have lower 
alcohol self-administration than the LR98. This might be due to the actual 
circumstances under which the animals have been tested, which will be 
discussed in section 1.2.4. 
Except for these behavioural differences, differences have also been found in 
the brains of these animals. Most importantly, dopaminergic activity in the 
limbic and cortical areas is different between HR and LR rats. Compared to 
LR rats, HR rats are characterized by a higher basal and stress-induced 
dopamine activity in the NAc, in combination with a lower basal 
dopaminergic activity in the mPFC183. In addition to the neurobiological 
differences, the HPA-axis reactivity of HR and LR rats was also different. 
When exposed to novelty, HR rats exhibited a higher and prolonged 
secretion of corticosterone compared to LR rats180,182,198. 
In conclusion, this model allows for studying the neurobiological substrate 
underlying the individual differences and the effects of late environmental 
factors on drug self-administration behaviour. However, at this point, this 
model does not permit the identification of a common genetic factor and is 
not suitable for studying the effects of early adverse life events on the 
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development of the phenotype. In order to study these effects, selective 
breeding should be started in order to evaluate whether the novelty-seeking 
trait is heritable and subsequently genetic analysis and early life 
manipulations could take place. 
 
1.2.1.2 High Grooming/Low Grooming model 
The High Grooming (HG)/Low Grooming (LG) animal model was recently 
developed by the group of Schoffelmeer and De Vries in Amsterdam 
(Netherlands) and uses the amount of stress-induced self-grooming on an 
elevated plus maze as a selection criterion. The group of rats grooming on 
the EPM was divided in an upper quartile (HG) and a lower quartile (LG). 
This animal model was developed to study the contribution of negative 
affect to the individual differences in vulnerability to drug addiction. Self-
grooming on the EPM is believed to reflect a strategy to cope with negative 
affect or stress. The self-grooming behaviour was postulated to be part of a 
dearousal process that may serve to restore the homeostatic status that was 
disturbed by stressful or anxiogenic stimuli108.  
Acquisition of cocaine self-administration under an FR1 schedule of 
reinforcement was not different between HG and LG rats. However, HG rats 
did reach higher breakpoints than LG rats under a PR schedule. This 
indicates, according to the authors, that self-grooming specifically predicts 
the translation of cocaine-induced subjective experiences into motivational 
goal-directed behaviour. HG and LG rats show no differences in locomotor 
activity when placed on an open field108.  
At the neurobiological level, HG rats are characterized by a lower 
dopaminergic activity in the mPFC and SN than LG rats, but no differences 
between the rats were found in the mesolimbic areas (i.e. VTA, NAc core 
and shell)109. However, following cocaine and saline self-administration, 
dopaminerigic reactivity in the NAc was reduced in HG rats as compared to 
LG rats, while the difference between HG and LG rats remained similar 
when compared to baseline levels109. Finally, differences in HPA-axis 
reactivity were also measured in these rats, revealing that plasma 
corticosterone levels following EPM exposure were higher in HG than in LG 
rats107. 
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This animal model has the same disadvantages as the HR/LR model, namely 
not allowing to investigate the contribution of genetic factors and early life 
events on the development of addictive behaviour at this point. In addition, 
this animal model is relatively new and needs more validation in order to be 
a good model for individual differences in vulnerability to addiction. 
 
1.2.2. Selection based on initial drug response 
1.2.2.1. High Cocaine Responders/Low Cocaine Responders 
The model of High Cocaine Responders (HCR) and Low Cocaine 
Responders (LCR) is based on the locomotor activity of the rat on an open 
field after administration of 10 mg/kg cocaine. A median-split was used to 
characterize rats as either HCR or LCR24,103. Obviously, HCR are more 
susceptible to the acute locomotor activating effects of cocaine than LCR. 
However, cocaine self-administration has not been assessed in these rats. 
Sensitization to the behavioural effects of cocaine has been studied in these 
rats, and showed that LCR exhibited a sensitization to cocaine, whereas 
HCR did not (activity in HCR was relatively high from the first injection 
onwards, but did not increase during the repeated treatment)201. This is not 
consistent with the HR/LR model, namely that HR rats, that like HCR show 
a greater initial response to the drug than LR, have been shown to sensitize 
to repeated  psychostimulant administration whereas LR rats do not. The 
contribution of the DAT has been examined in the HCR and LCR rats. 
While total amounts of DAT were not different between the rats, the [3H]DA 
uptake in the dorsal striatum was higher in HCR than in LCR, suggesting 
that the cell surface expression of the DAT is, at least in part, responsible for 
the differential cocaine-induced locomotion between these rats103. 
The major disadvantage of this model, apart from the disadvantages already 
mentioned in both the HR/LR and HG/LG model, is that the phenotype of 
the rats does not seem to be constant. Upon retesting of the animals, the 
original classification into HCR and LCR was not found103. In addition, 
underlying basal neurobiological differences can never be investigated, 
because animals always have to be treated with cocaine in order to be 
classified. This could also interfere with studying late environmental factors 
on the behaviour of these rats, since, for instance, prior exposure to the drug 
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could modulate the individuals stress response and the subsequent drug 
response. 
 
1.2.3.     Selective breeding 
1.2.3.1     High Alcohol Drinking/Low Alcohol Drinking rats 
Several laboratories have developed rat models with individuals displaying 
differences in the amount of alcohol self-administration. These rats have 
been selectively bred for their propensity to self-administer alcohol, leading 
to High/Low Alcohol Drinking rat lines (HAD vs LAD), the (sardinian) 
Alcohol Preferring ((s)P) and Non Preferring ((s)NP) rat lines and the ALKO 
alcohol/non-alcohol (AA vs ANA) rat lines. Without going into great detail 
about these different lines, a few characteristics are important to notice. 
Besides the obvious differences in alcohol drinking behaviour, another 
behavioural difference has been found between P and NP rats. Namely, 
locomotor stimulation following amphetamine administration was higher in 
(s)NP than in (s)P rats60,161.  
Beside these behavioural differences between the HAD/(s)P/AA and the 
LAD/(s)NP/ANA rats have been found in the dopaminergic mesolimbic 
system. For example, TH levels in the limbic system of sP rats are lower 
than those of the sNP rats42. Lower dopamine contents have been found in 
the NAc of P and HAD rats as compared to NP and LAD rats160,171,172. In 
addition, it was found that DAT levels in the limbic system were also lower 
in sP rats as compared to sNP rats43.  
Finally, basal HPA-axis activity has also been measured and showed that 
CRF levels were lower in NP rats as compared to P rats78. Stress-evoked 
responses of the HPA-axis have not been measured in these rats. 
Although all these rat lines have been bred and thus allow for studying a 
genetic factor in the determination of alcohol drinking behaviour, this has 
not been studied yet. Also, early and late life events contributing to the 
development of the actual phenotype have not been investigated in these rat 
lines. 
 
1.2.3.2.    Apomorphine-susceptible/apomorphine-unsusceptible rats 
The apomorphine-susceptible (APO-SUS) and apomorphine-unsusceptible 
(APO-UNSUS) rat model was developed many years ago by Cools and co-
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workers54,85. These rats were originally selected on the basis of their 
stereotype gnawing response to the D1/D2 agonist apomorphine. After a 
subcutaneous injection with 1.5 mg/kg apomorphine, rats were placed in a 
box containing a modified hole board. The box contains 32 holes, each of 
which is surrounded by five concentric ridges on which the rat can gnaw. 
The gnawing sound is detected by a microphone underneath the central 
cubicle in the box and fed into a computer. Analysis of the gnawing scores 
of a normal population of Wistar rats led to the observation that a bimodal 
variation in the gnawing scores was present in this population. Animals 
displayed either a very high gnawing score (≥500 per 45 min), or a very low 
gnawing score (≤10 per 45 min), with only a very small population of rats in 
between54,85. The high scoring animals were then labelled APO-SUS and the 
low-scoring animals APO-UNSUS rats. A selective breeding process was 
started with these animals, resulting in a stable APO-SUS and APO-UNSUS 
population over the years. Many behavioural, neurobiological, 
endocrinological, physiological, genetical and developmental differences 
have been established between the rat lines, only some of which will be 
described in this section23,52,54,55,63-65,81-83,85,86,125,188,196,197,210,212,223,234-236,238. At 
the behavioural level, APO-SUS rats are characterized by a higher locomotor 
activity when placed on an open field than APO-UNSUS rats, thus in this 
respect being similar to HR while APO-UNSUS rats are similar to LR. With 
respect to self-administration behaviour, several studies have been 
conducted. First, when under non-challenged conditions, APO-UNSUS rats 
self-administered more alcohol and cocaine than APO-SUS rats210,236,238. 
This was reversed when a (mild) environmental challenge was 
presented236,238. APO-SUS rats also had a higher cocaine-induced 
conditioned place preference than APO-UNSUS rats, indicative of a 
difference in “reward-sensation” between these rat lines239. 
At the neurobiological level, pronounced differences in the dopaminergic 
system have been shown. For instance, the number of striatal D2/D3 receptor 
binding sites and D1 receptor mRNA levels were higher in APO-SUS rats 
than in APO-UNSUS rats196. In addition, TH mRNA levels in the SN were 
higher in APO-SUS than in APO-UNSUS rats196. More recently, differences 
in DAT levels were also found, showing that striatal DAT levels were lower 
in APO-UNSUS compared to APO-SUS rats237.  
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At the level of the HPA-axis, APO-SUS rats, like HR and HG rats, had 
higher and more prolonged levels of corticosterone and ACTH after 
exposure to novelty than APO-UNSUS rats197. 
At this point it is interesting to notice that this animal model has a genetic 
component. The first clue to this notion was that cross-breeding APO-SUS 
with APO-UNSUS rats resulted in intermediate gnawing scores of the 
offspring82,85. Although this is an indication that a genetic component plays a 
role in determining the phenotype of the animal, solid evidence was 
presented only recently. While APO-UNSUS rats appeared to have three 
copies of the gene Aph-1b, APO-SUS rats have only one or two copies of 
this gene52,53. Although the exact relevance of the difference in this genetic 
component is not clear yet, it is of critical importance to realise that the Aph-
1b gene plays an important role in development. Indeed, APO-SUS rats had 
a slower development than APO-UNSUS rats. Thus, it is tempting to 
speculate that the difference in the Aph-1b gene in these animals is related to 
their difference in developmental speed63,86. 
In addition to the genetic component and the effects of environmental 
challenges on drug intake of APO-SUS and APO-UNSUS rats, early 
environmental factors also play an important role in determining the 
phenotype of these rats. It has been shown that maternal deprivation on 
postnatal day 9 can changed the phenotype of an APO-UNSUS rat in the 
direction of an APO-SUS rat, whereas cross-fostering on postnatal day 0 
changed the phenotype of an APO-SUS rat in the direction of an APO-
UNSUS rat85. In addition, it has been shown that maternal deprivation also 
changed the cocaine self-administration of APO-UNSUS rats into an APO-
SUS like intake pattern240. 
Summarizing all these data, it appears that the combination of genetic, early 
life events and late environmental factors are essential in producing the 
ultimate phenotype of the rat. Since all these factors can be investigated in 
the APO-SUS and APO-UNSUS model, and some of which already have 
been investigated, this model provides an excellent animal model to 
investigate the so-called three hit model, which states that a disorder (such as 
addiction) results from an interaction between genetic factors, early life 
events and late environmental factors80,86. 
 
 19
Chapter 1                                                                              General introduction 
1.2.4 Common factors 
When reviewing all these animal models, some common factors can be 
observed, but also some possible discrepancies. First, individual differences 
in drug self-administration can be observed in a number of different animal 
models. However, at first sight, there seem to be some contradictions. While 
Piazza and co-workers first postulated that the response to novelty is a 
predictor for the amount of drug self-administration, this is not per se the 
case as shown in the Nijmegen HR and LR and the APO-SUS and APO-
UNSUS rat model. Especially the last mentioned model has challenged this 
notion. It appears that the circumstances under which drug self-
administration is measured plays a critical role in determining the individual 
differences and, especially, the presence of (environmental) stressors should 
be taken into account. It can therefore better be postulated that the response 
to novelty is correlated with drug self-administration under certain 
circumstances: a high response to novelty is coupled to a high propensity for 
drug self-administration under (environmentally) challenged conditions, 
while a low response to novelty is coupled to a high propensity for drug self-
administration under (environmentally) non-challenged conditions. 
Keeping this in mind, it also appears that rats that show a low response to the 
acute effects of psychostimulant administration, display a higher drug self-
administration when tested under non-challenged conditions (for example, 
the Nijmegen HR/LR and the P/NP rat lines). 
At the neurobiological level, HR and NP are characterized by a more intense 
dopaminergic innervation of the NAc than LR and P rats, while the 
dopaminergic innervation of the mPFC of HR rats was lower than that of the 
LR rats. These data indicate that the limbic and cortical dopaminergic 
systems are of crucial importance in determining individual differences in 
the vulnerability to drug addiction. More specifically, low dopaminergic 
activity in the NAc is coupled to a high drug self-administration under non-
challenged conditions, while a high dopaminergic activity in the NAc is 
coupled to a high drug self-administration under challenged conditions.  
Differences in the amount of DATs might also underlie individual 
differences. DAT levels are lower in striatal regions of sP and APO-UNSUS 
rats. These differences in the DAT may certainly play an important role in 
mediating the animal’s response to drugs such as amphetamine and cocaine. 
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The third factor that is important in determining an individual’s response to 
addictive drugs is the (re)activity of the HPA-axis. Animals that have a 
higher acute response to psychostimulant administration also appear to have 
a higher (re)activity of the HPA-axis. HR have a higher release of 
corticosterone than LR after exposure to novelty. Stronger evidence for the 
involvement of the HPA-axis comes from studies in which the adrenal 
glands have been removed from these animals. When removing the adrenal 
glands and resupplying corticosterone by insertion of corticosterone-
releasing subdermal pellets, the differences between HR and LR rats in the 
psychomotor effects of morphine are completely gone70, implying that 
corticosterone is also an important factor in determining the response to 
drugs of abuse. 
 
In conclusion, environmental factors, genetic factors, the state of the limbic 
and cortical systems and the (re)activity of the HPA-axis are all factors that 
are of crucial importance in determining whether an animal is prone to drug 
self-administration or not.  
 
1.3. The neurobiology of drugs of abuse 
Several stages can be identified in drug addiction, namely the acquisition or 
initiation of drug use, the maintenance phase, withdrawal or abstinence 
(acute and protracted) and relapse. All these phases are accompanied by their 
own neurobiological changes, and each class of drugs (e.g. 
psyhcostimulants, opioids, alcohol) exerts different effects on the brain. 
Discussing all these neurobiological changes is far beyond the scope of this 
thesis and thus the main focus will lie on the acute (reinforcing) effects of 
psychostimulant drugs such as cocaine and amphetamine.  
 
1.3.1. The reward system 
Drugs of abuse act upon the natural reward system of the brain, which is 
responsible for providing pleasurable feelings following for instance eating 
or sex. This reward system is present in all individuals and thus every 
individual is biologically prone to addiction. Although drugs of abuse have 
no intrinsic ability to serve a biological need, they do lead to a much stronger 
activation of this reward system than natural reinforcers126. The activation of 
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the dopaminergic system is much stronger and longer lasting after using 
drugs than following natural reward behaviours. This leads to the assumption 
that addictive drugs have a competitive advantage over most natural stimuli. 
Thus, drugs of abuse “attack” the natural reward system and then “hijack” it, 
making drug addicts progressively less sensitive to natural rewards and more 
dependent on the drug. However, although drugs of abuse act upon the 
natural reward system, it has been shown that natural reinforcers such as 
food and water increase cell firing in a subset of NAc neurons that is 
different from the subset of neurons that is activated by cocaine 
reinforcement38-40 (see also203). 
 
 
The reward system of the brain (from124) 
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1.3.2. The dopaminergic system 
A large body of literature has implicated the central dopaminergic system as 
the most important neurotransmitter system mediating the reinforcing effects 
of psychostimulants251. For instance, systemic administration of dopamine 
receptor antagonists have been found to be effective in blocking cocaine and 
amphetamine self-administration in rats62,73. The mesocorticolimbic 
dopamine system, projecting from the ventral tegmental area (VTA) to the 
nucleus accumbens (NAc), prefrontal cortex (PFC), olfactory tubercle and 
the amygdala, is of special importance89,191. Increases in dopamine 
neurotransmission in the NAc, measured by in vivo microdialysis, have been 
found during cocaine self-administration115. Administration of the 
neurotoxin 6-hydroxydopamine (6-OHDA) in the NAc, which destroys 
dopaminergic neurons, has been shown to produce extinction-like 
responding in cocaine and amphetamine self-administration153,192. 
Microinjection of the D1 receptor antagonist SCH23390 in brain areas such 
as the NAc shell, amygdala and the (dorsolateral) bed nucleus of the stria 
terminalis (BNST) has been found to decrease the reinforcing properties of 
cocaine35,88. These data all indicate a crucial role for dopamine transmission 
in the mesocorticolimbic system in the reinforcing properties of 
psychostimulants.  
In humans it has also been shown that the limbic and cortical systems are of 
importance in addiction229,245. For example, using imaging studies, it was 
shown that subcortical brain regions including the NAc are activated after 
infusion of cocaine and in response to cue-induced cocaine craving22,45, 
further underlining the importance of this system in addiction. In addition, 
positron emission tomography (PET) studies have revealed that the 
reinforcing effects of psychostimulants are coupled with increases in 
dopamine concentrations and D2 receptor occupancy in limbic regions due 
to blockade of the dopamine transporter244,246.  
 
1.3.4. Cellular mechanism of cocaine and amphetamine 
Both substances exert their action via the dopamine transporter (DAT). The 
DAT is a presynaptically located protein in the membrane of the nerve 
terminal. Its function is to remove dopamine that is released into the synaptic 
cleft back into the terminal. Cocaine is a powerful blocker of the DAT, thus 
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blocking the reuptake of dopamine from the synaptic cleft and thereby 
increasing extracellular levels of dopamine190. The ability of cocaine to block 
the DAT appears to be crucial for its reinforcing effects140,189,190.  
The amount of increase of extracellular dopamine after cocaine 
administration is impulse-dependent: a higher release of dopamine will result 
in a higher amount of extracellular dopamine left in the synaptic cleft after 
DAT blockade.  
At this point it is interesting to notice that the dopaminergic nerve terminal 
contains at least two different dopamine pools, namely the cytosolic alpha-
methyl-paratyrosine (aMpT) sensitive dopamine pool and the  vesicular 
reserpine sensitive dopamine pool7,144,254,255. These pools can be depleted by 
the TH inhibitor aMpT and the vesicular monoamine transporter (VMAT) 
blocker reserpine, respectively105,168. The effects of cocaine and 
amphetamine are mediated via different pools. Namely, in addition to 
blockade of the DAT, which is the major action of cocaine, it also has a 
dopamine-releasing component, stimulating dopamine release preferentially 
from the so-called vesicular reserpine-sensitve dopamine pool114,115,185.  
Amphetamine is a substrate for the DAT, entering the nerve terminal 
through the DAT. Subsequently, the function of the DAT is “reversed” and 
amphetamine promotes the release of (cytosolic, aMpT sensitive) dopamine 
through the DAT and thus causing an increase in extracellular dopamine 
levels143,144,185.  
The amount of increase in extracellular dopamine levels by amphetamine is 
not impulse-dependent: dopamine will be released independent of the 
activity state of the neuron. Apart from promoting release via reverse 
transport, amphetamine also blocks the DAT, especially at higher doses143. 
In conclusion, while cocaine and amphetamine both cause an increase in 
extracellular levels of dopamine, they do so in different ways an act upon 
different intraneuronal dopamine pools. 
 
Finally, it should be noted that of course not only the dopaminergic system 
plays a role in addiction. Cocaine, for instance, also blocks the serotonin 
transporter and the noradrenaline transporter, thus also increasing 
extracellular levels of these neurotransmitters195,233. Furthermore, other 
systems have also been implicated, such as the GABA-ergic, cholinergic, 
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glutamatergic and opioid systems10,136. However, these systems have not 
been investigated in such great detail as dopamine. 
 
1.4. Aim and outline of this thesis 
While individual differences in drug addiction is a well-known phenomenon, 
the underlying neurobiological mechanisms are still not fully elucidated. A 
wide variety of behavioural studies have been conducted in APO-SUS and 
APO-UNSUS rats, but elucidating differences in the neurobiology between 
these rat lines has only just begun. Therefore, the central aim of this thesis 
was to investigate what neurobiological features could contribute to the 
differential response of APO-SUS and APO-UNSUS rats to drugs of abuse. 
As mentioned previously, APO-SUS and APO-UNSUS rats differ in the 
amount of alcohol and cocaine self-administration and represent a good 
animal model for neuropsychiatric disorders such as addiction. This animal 
model is also very suitable to study the so-called “three-hit model” for the 
aetiology of these disorders. 
In chapter 2, the underlying pre-existing differences in the dopaminergic 
system of the NAc was investigated in APO-SUS and APO-UNSUS rats, 
using immunocytochemistry for the enzyme tyrosine hydroxylase (TH), 
which is the rate-limiting enzyme in dopamine synthesis. 
In chapter 3, the response of the dopaminergic system in the NAc to the 
mild stressor novelty of APO-SUS and APO-UNSUS rats was investigated, 
using both immunocytochemistry for TH and in vivo microdialysis, 
measuring the extracellular levels of dopamine in the NAc in freely moving, 
awake rats. 
In chapter 4, APO-SUS and APO-UNSUS rats were injected with cocaine. 
Subsequently, TH immunocytochemistry was used on the NAc, medial PFC 
(mPFC), VTA and substantia nigra, pars compacta (SNc). In addition, 
immunocytochemistry for the enzyme dopamine-beta-hydroxylase (DBH), 
which converts dopamine into noradrenaline was used on the mPFC.  
In chapter 5, the cellular mechanism underlying the responsiveness of APO-
SUS and APO-UNSUS rats to amphetamine using the prepulse inhibition 
paradigm (PPI) was investigated. To this end, the TH inhibitor alpha-methyl-
paratyrosine (aMpT) was used to block the dopamine synthesis and the 
vesicular monoamine (VMAT) blocker reserpine was used to prevent 
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sequestering of dopamine into vesicles. These substances thus have a 
differential effect on intraneuronal dopamine pools. The effect of these 
substances was tested on the amphetamine-induced response of APO-SUS 
and APO-UNSUS rats on PPI, in order to investigate what the origin of 
dopamine was in both rat lines following amphetamine treatment. 
In chapter 6, the differential response of APO-SUS and APO-UNSUS rats 
to cocaine was investigated, again using PPI. The effects of cocaine on PPI 
were further studied using the D2 antagonist remoxipride, the alpha1-
adrenoceptor antagonist prazosin and the 5HT2-antagonist ketanserin. 
Finally, chapter 7 summarizes and discusses the outcome of all studies 
described in this thesis. 
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Abstract 
Individual variability in behavioural responses to stressors such as novelty 
and drugs of abuse is a well-known phenomenon in both animals and man. 
These individual differences are largely associated with differences in 
dopamine transmission in mesolimbic areas such as the nucleus accumbens. 
Apomorphine-susceptible (APO-SUS) rats and apomorphine-unsusceptible 
(APO-UNSUS) rats serve as a valid animal model for individual differences 
and these two types of rat differ in a number of behavioural, physiological, 
endocrinological and pharmacological parameters. In order to study the 
differences in the catecholaminergic network in the nucleus accumbens, 
possibly underlying at least some of the differences between the two types of 
rat, we quantified the extent of the tyrosine-hydroxylase immunoreactive 
(TH-IR) network and the number of TH-IR varicosities in subareas of the 
nucleus accumbens core and shell in naïve rats. This study shows that the 
nucleus accumbens of APO-SUS rats have a more extensive fibre network 
and more varicosities than the nucleus accumbens of APO-UNSUS rats, and 
that the subarea of the shell contains more varicosities than the subarea of 
the core. 
These data provide a basis for further studying the structural and 
neurochemical properties of the nucleus accumbens contributing to 
individual differences in response to stressors such as novelty and drugs of 
abuse.  
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Introduction 
Rats, like other mammals including man, show remarkable individual 
differences in stress coping styles as well as differences in the response to 
drugs of abuse54,57,67,98,198.  These individual differences appear to be 
primarily associated with differences in the mesolimbic dopaminergic 
system110,157,224,230. The Nucleus Accumbens (NAc) is an important basal 
forebrain structure that is part of the mesolimbic system and is often 
regarded as an interface between the motor and limbic systems of the 
brain59,166. The NAc consists of two major areas, the core and the shell, 
which differ in both structural and functional respects162,187,257. Whereas the 
core is predominantly part of the nigrostriatal motor system and is involved 
in the control of voluntary movements, the shell is predominantly part of the 
limbic system and is involved in stress responses and responses to addictive 
drugs, such as cocaine and amphetamine12,71,252. 
Many years ago we started to pharmacogenetically select Wistar rats on the 
basis of their gnawing response to the dopamine D1/D2-receptor agonist 
apomorphine and bred them for over 30 generations. The so-called 
apomorphine-susceptible (APO-SUS) rats display a much larger gnawing 
score in a 45-minute period than apomorphine-unsusceptible (APO-UNSUS) 
rats54. Throughout the years these two types of rats have proven to be a valid 
model for studying individual differences. They display numerous 
behavioural, physiological, endocrinological, pharmacological and 
neurochemical differences23,64,125,212. For example, APO-SUS rats are much 
more sensitive to mild stressors than APO-UNSUS rats, at the behavioural 
level as well as at the level of the HPA-axis54,125,196. Furthermore, APO-SUS 
and APO-UNSUS rats have a differential vulnerability to drugs of abuse: in 
their home cage, APO-UNSUS rats drink more alcohol than APO-SUS 
rats210.  
The fact that APO-SUS and APO-UNSUS rats provide a valid model for 
studying individual differences in response to stressors and drugs of abuse, 
combined with the role of the mesolimbic dopamine system in the 
determination of these individual differences, led us to investigate the 
catecholaminergic system in the NAc shell and core of naïve APO-SUS and 
APO-UNSUS rats. Since APO-SUS rats are more sensitive to mild stressors 
and since especially the shell area of the NAc is important in regulating the 
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animal’s response to stress, we hypothesise that the shell region of the NAc 
in APO-SUS rats has a more extensive catecholaminergic structure than the 
shell region of the APO-UNSUS rats. To test this hypothesis light-
microscopic immunocytochemistry and morphometry was carried out on 
subareas in the NAc shell and core, using an antibody against tyrosine 
hydroxylase, which is the rate-limiting enzyme in the synthesis of 
catecholamines, including dopamine and noradrenaline.  
The analysis of the TH-IR innervation of the NAc was restricted to two 
specific subareas in dorsomedial parts of the shell and the core. Although it 
is known that the shell has a heterogeneous pattern of catecholamine 
distribution, it was decided to restrict quantifications to the subareas 
depicted in Figure 1, since drug-induced changes in tyrosine hydroxylase 
occur especially in this subarea of the shell in Sprague-Dawley rats227. 
Given the rather homogeneous pattern of catecholamine distribution in the 
core, we focussed on a subarea of the core that has been found to mediate 
core-specific functions58,132. 
 
Material and Methods 
Animals  
Male rats of the 30th and 31st generation of the apomorphine-susceptible rat 
line (APO-SUS, n=6) and the apomorphine-unsusceptible rat line (APO-
UNSUS, n=6), aged 2.5 months, were used. The lines have been bred and 
reared in the Central Animal Laboratory of the University of Nijmegen, and 
were housed in air humidity-controlled rooms, at 21 ± 2 oC, with a 12/12 
light/dark cycle (lights on at 07.00). Food and water were available ad 
libitum in the home cages. All experiments were carried out in accordance 
with institutional, national and international guidelines for animal care and 
the Dutch law concerning animal welfare.  
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Experimental set-up 
Two groups of rats, one consisting of 6 APO-SUS and the other of 6 APO-
UNSUS rats, were individually housed in standard macrolon type III cages 
(42 x 26 x 20 cm) for 3 days.  
 
Tissue processing 
Rats were deeply anaesthetised by intraperitoneal administration of sodium 
pentobarbital (60 mg/kg), and transcardially perfused with 50 ml 0.9% 
NaCl in distilled water, followed by 300 ml 4% paraformaldehyde in 0.1 M 
sodium phosphate-buffered saline (PBS; pH 7.3). Then, brains were 
removed and postfixed in the same fixative, for 16 hrs at 4 oC. Coronal 
vibratome (Leica, Nussloch, Germany) sections (50 μm) containing the 
NAc, were rinsed in PBS and in 0.3% H2O2 in PBS. Subsequently, sections 
were pretreated with PBS containing 0.1% BSA and 0.3% Triton-X-100 for 
30 min, and then incubated with anti-TH serum (1:20,000; Diasorin, 
Stillwater, MN, USA) for 16 hrs. After rinsing, sections were incubated in 
goat-anti-mouse (1:1,500, Vector Laboratories, Burlingame, Canada) for 90 
min, rinsed, incubated with avidin-biotin conjugate (Vector ABC Elite, 
Vector Laboratories, Burlingame, California) for 90 min. After ABC 
incubation and rinsing, sections were treated with 0.025% 3’3’-
diaminobenzidine containing 0.15% nickel ammonium sulphate for 10 min. 
Subsequently the immunostaining was developed by treating the sections 
with the former solution containing .00015% H2O2, for 10 min, and rinsed. 
Serial sections were mounted on poly-L-lysine-coated slides, dehydrated 
and coverslipped with Entellan®. 
 
Morphometry  
Morphometry of the TH-IR fibre network was carried out in the left NAc, in 
the section approximately -1.7 mm from Bregma (Interaural10.70 mm) 
according to Paxinos and Watson178. For the shell, a vertical line from the 
lateral ventricle and a horizontal line from the middle of the anterior 
commissure were drawn. These lines represented the dorsal and lateral 
border of the sampling area. For the core, a sampling area centrally between 
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the anterior commissure and the lateral ventricle was taken (see Fig. 1). 
Both regions were chosen for reasons mentioned in the Introduction. 
Morphometry was carried out using a Nikon (Nikon, Tokyo, Japan) light 
microscope with an eyepiece graticule, at a final magnification of x1,000. 
The total length of the TH-positive fibres in the sampling area (‘extent’ of 
the fibres) was quantified by direct line-intersection counting. The extent of 
the fibre network, expressed in μm/100 μm2, was calculated according to 
the formula of Loud et al., 1965150: l = (πc/2d) x (M/1000), in which c is the 
number of intersections the fibres make with the grid lines, d is the distance 
measured along the grid lines, and M is the magnification. The numerical 
density of varicosities was expressed as number/1,000 μm2. All 
morphometric analyses were strictly performed as a blind study. 
Photomicrographs were made on a Zeiss Axiovert 135 TV microscope 
(Zeiss, Göttingen, Germany) equipped with a Coolsnap fx digital camera 
(Roper Scientific, Tucson, USA). 
 
Fig  1. The grey squares indicate the sampling areas for the NAc core and shell. 
(Coordinates according to Paxinos and Watson) 
Cpu = caudate-putamen, Ac = anterior commissure  
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Statistical analysis 
The data were analysed by a two-way ANOVA, with ‘structure’ (core, 
shell) and ‘rat line’ (APO-SUS, APO-UNSUS) as independent variables. 
Analyses were done using SPSS 9.0 software (SPSS Inc., Chicago, Il, 
USA). Differences were considered significant when P<0.05. 
 
 
 
Fig 2. TH-immunoreactive staining of the nucleus accumbens. (A) Photograph of 
TH-immunoreactive staining in the NAc. (B) Photograph of a section of the NAc on 
which the first antibody was omitted. (C) Magnification of (A), in which the 
delineation between core and shell clearly can be observed (ac = anterior 
commissure). (D) Micrograph of fibres in the shell. (E) Micrograph clearly 
demonstrating thick, varicose fibres, taken from the core. (F) Micrograph F 
demonstrates clear varicosities.. Scale bars (A-B) = 1mm, (C) = 500 μm, (D) = 
50μm, (E) = 10μm, (F) = 5μm.   
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Results 
General morphological characteristics 
The NAc of APO-SUS and APO-UNSUS rats contained unstained 
perikarya and numerous axonal fibres, which were stained with the anti-TH 
serum. In all experimental groups, the TH-IR axons and varicosities were 
well-delineated, because they were strongly, homogeneously and 
completely stained, making them stand out clearly and sharply against the 
unstained background (Fig. 2a, c-f). This picture held for both the core and 
the shell subareas of the NAc in all experimental groups. No positive 
staining was observed when the first antiserum had been omitted (Fig. 2b).  
 
Comparison of naive APO-SUS vs. naive APO-UNSUS rats (group A) 
Fibre extent (Fig. 3a). Morphometry showed that there were significant 
differences between the rat lines (F1.20=9.519, P<0.01): the fibre extent was 
larger in APO-SUS rats compared to APO-UNSUS rats. No differences 
between the shell and core subareas were found. No interaction between the 
factors rat line and structure was found.   
Varicosities (Fig. 3b). Significant differences were found between the rat 
lines (F1.20=24.3, P<0.01): the number of varicosities was higher in APO-
SUS rats compared to APO-UNSUS rats. Moreover, significant differences 
between the shell and core subareas were identified (F1.20= 12.9, P<0.01): 
the varicosities were more numerous in the shell subarea than in the core 
subarea. No interaction between the factors rat line and structure was found.  
Overall effects in naive APO-SUS and APO-UNSUS rats 
The NAc of APO-SUS rats contained a more extensive fibre network and 
more varicosities than the NAc of APO-UNSUS rats. Furthermore, the shell 
subarea of the NAc contained more varicosities than the core subarea of the 
NAc in both rat lines.   
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Fig. 3. Comparison between naive APO-SUS and naive APO-UNSUS rats. APO-
SUS rats have more extensive fibre network than APO-UNSUS rats (A) and a larger 
number of varicosities (B) and the shell subarea contains more varicosities than the 
core subarea (B). The extent of the fibre network and the numerical density of 
varicosities are expressed as mean ± S.E.M. 
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Discussion 
In the present study we used immunocytochemistry for the enzyme TH to 
delineate the catecholaminergic fibre network. TH is the rate-limiting 
enzyme in the biosynthesis of catecholamines, including dopamine and 
noradrenaline. The vast majority of the fibres innervating the NAc contain 
dopamine but some parts of the NAc shell also contain noradrenergic 
fibres18,66. Moreover, there is strong evidence that mesolimbic noradrenaline 
plays an important role in the regulation of dopamine release in the NAc230. 
On the other hand, the former studies have shown that noradrenaline-
containing fibres are only present in the caudal regions of the shell. These 
regions are much more caudal than the regions we have investigated and 
therefore it is unlikely that the TH-IR fibres and varicosities that have been 
quantified in this study are noradrenergic. However, this remains to be 
investigated. 
An additional point of discussion concerns the methodology used. Given the 
fact that TH-immunocytochemistry is not strictly quantitative, but that it 
provides a very strong staining, in which the TH-IR fibres stand out clearly 
against the background and are well delineated, the present data are 
described in terms of changes in the numbers and extent of TH-IR elements 
rather than in terms of changes in the amount (staining intensity) of TH in 
the area under study226,227.  
A final remark in this section concerns the nature of the varicosities. The 
TH-IR varicosities appear at the light microscopical level as swellings of 
axonal processes. Our observations do not permit to determine the exact 
nature of these swellings, but on the basis of ultrastructural data on the 
presence of TH in the rat brain and more in particular in the NAc, it can be 
assumed that some of the varicosities are sites in which neurotransmitter 
vesicles are being stored. However, the majority of varicosities represent 
presynaptic release sites for dopamine or noradrenaline101,116,207,247,256. 
 
Differences between the TH-IR network in the shell and the core of the NAc. 
The present study confirms earlier reports that the dopaminergic innervation 
of the chosen shell subarea of the NAc is more extensive than that of the 
chosen core subarea247,256: our data indeed show that the shell subarea 
contains a larger number of TH-IR varicosities than the core subarea. This 
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also underlines TH-immunocytochemistry as a valid method for assessing 
differences in catecholaminergic innervation. As mentioned in the 
Introduction, we focused our attention on a circumscribed part of the shell, 
because the function of especially that part is involved in cocaine 
addiction227, a feature known to differ between APO-SUS and APO-
UNSUS rats238. Because the core subarea chosen is representative for the 
core, the type-specific differences found in the core subarea may be 
assumed to hold for the core as a whole.  
 
Differences between the TH-IR innervation in the NAc of APO-SUS and 
APO-UNSUS rats.  
APO-SUS and APO-UNSUS rats show various behavioural, 
immunological, endocrinological and pharmacological differences and, by 
definition, have a different reactivity to apomorphine23,54,125,196. We show for 
the first time that these two Wistar rat lines also differ considerably in the 
catecholaminergic innervation of the NAc: compared to APO-UNSUS rats, 
APO-SUS rats have a more extensive fibre network and many more 
varicosities across the shell and the core subareas studied. Our data 
substantiate the hypothesis raised in the Introduction that the NAc in APO-
SUS rats contains a more elaborate catecholaminergic system than the NAc 
in APO-UNSUS rats.   
As mentioned in the introduction, APO-UNSUS and APO-SUS rats differ 
in their response to drugs of abuse. In this respect, they show close 
resemblance to the so-called alcohol-preferring (P) and alcohol-
nonpreferring (NP) rat lines. These rats have been selectively bred on the 
basis of their alcohol preference and the P rats are in that respect 
comparable to APO-UNSUS rats, which drink more alcohol in their home 
cage than APO-SUS rats210. Furthermore, P rats are less sensitive to the 
motor-stimulating effects of amphetamine than NP rats are60,161 and develop 
less gastric ulcers than NP rats204, a feature that is comparable with APO-
UNSUS rats64. When taking a closer look at brain neurochemistry of these 
two types of rats, P rats appear to have lower levels of dopamine in the 
NAc172 and lower levels of TH-IR in the shell of the NAc42,259, data that are 
consistent with the results described in this study.  
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Therefore these data suggest that rats that consume more drugs with 
addictive properties, such as alcohol in their home cage are characterised by 
a relatively inactive basal mesolimbic dopaminergic system.   
In conclusion, we have shown that APO-SUS rats have a more extensive 
TH-IR fibre network and more varicosities than APO-UNSUS rats. Given 
the fact that it is known that APO-SUS and APO-UNSUS rats differ in the 
response to stressors, the results of this study provide a basis for further 
studies on the structural and neurochemical properties of parts of the NAc 
contributing to individual differences in susceptibility to different stressors 
such as novelty and drugs of abuse. 
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Abstract 
Individual differences in responses to mild, acute stressors in laboratory 
animals have commonly been observed in behavioural tests and at the level 
of hypothalamic-pituitary-adrenal axis responses. These differences are 
associated with dopamine transmission in the nucleus accumbens. Although 
the effect of mild stressors on dopamine transmission has been studied with 
microdialysis, it has not been studied at the level of the catecholaminergic 
network in the nucleus accumbens. 
In this study we have used microdialysis to measure extracellular 
concentrations of dopamine in vivo and immunocytochemistry for the 
enzyme tyrosine hydroxylase to assess the effect of a single exposure to 
novelty on the neurochemistry of the nucleus accumbens in apomorphine-
susceptible and apomorphine-unsusceptible rats. These rats are a valid 
animal model for studying individual differences in responses to 
environmental stressors and drugs of abuse. 
We demonstrated that a mild stressor like novelty increased the extracellular 
concentration of dopamine in the nucleus accumbens in apomorphine-
susceptible rats to a larger and longer-lasting degree than in apomorphine-
unsusceptible rats. Furthermore we demonstrated that novelty increased the 
tyrosine hydroxylase-immunoreactive fibre network in the nucleus 
accumbens shell of apomorphine-susceptible rats, which are rats that are 
particularly reactive to stressors, but not in the shell of apomorphine-
unsusceptible rats, which are rats that are relatively stress-resistant.  
In conclusion, we have shown that the accumbal dopaminergic system of 
apomorphine-susceptible rats is more sensitive to an environmental stressor 
than that of apomorphine-unsusceptible rats. Combined with the fact that 
these animals also differ in their sensitivity to drugs of abuse, which are 
known to affect the dopaminergic system, these data provide a solid basis for 
further studying the differences in the dopaminergic responsiveness to drugs 
of abuse between apomorphine-susceptible and apomorphine-unsusceptible 
rats. 
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Introduction  
Apomorphine-susceptible (APO-SUS) and apomorphine-unsusceptible 
(APO-UNSUS) rats were originally selected from a normal population of 
Wistar rats on the basis of their gnawing response to the dopamine D1/D2-
agonist, apomorphine54. These rats have been bred for over 30 generations 
and represent an important animal model for studying individual differences 
in responses to environmental stressors and drugs of abuse54,210. Apart from 
the fact that APO-SUS rats show a much stronger gnawing response to 
apomorphine than APO-UNSUS rats, it has been shown that these rats also 
differ in other aspects of the dopaminergic system. Tyrosine hydroxylase 
(TH) messenger RNA levels in the dopaminergic cell bodies are higher in 
APO-SUS than in APO-UNSUS rats. In addition the dopamine D2 receptor 
binding and D1 mRNA levels in striatal regions are higher in APO-SUS rats 
than in APO-UNSUS rats196.  
Besides differences in the dopaminergic system, many behavioural and 
physiological differences have consistently been found between APO-SUS 
and APO-UNSUS rats. In particular, APO-SUS rats are more sensitive to 
environmental stressors: when placed on an open field, APO-SUS rats have 
a higher locomotor activity and habituate much later than APO-UNSUS 
rats54,82. In addition, at the level of the hypothalamic-pituitary-adrenal (HPA) 
axis responses APO-SUS rats are again more sensitive to novelty. Placement 
in a novel cage resulted in  higher and more prolonged plasma 
adrenocorticotropic hormone (ACTH) and corticosterone response in APO-
SUS rats and  prolonged circulating free corticosterone levels197. Studies 
have revealed that these two types of rat also differ in their vulnerability to 
drugs of abuse. When investigated in their home cage, APO-UNSUS rats 
consume more alcohol than APO-SUS rats do210. However, very recently it 
has been found that the amount of alcohol consumption is highly dependent 
on the environmental conditions: when the animals are challenged, it appears 
that APO-SUS rats consume more alcohol than APO-UNSUS rats236. 
Therefore it is important to realise that the environmental context can 
strongly influence the outcome of behavioural studies.  
The aim of this study was to better understand which neuronal mechanisms 
might be involved in individual differences in behavioural responses to 
stressors. It is known that robust responding to an environmental stressor 
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such as novelty is related to alterations in dopamine release, especially in the 
nucleus accumbens (NAc)11,224. Several studies on so-called high responders 
(HRs) and low responders (LRs) to novelty have shown that the extracellular 
concentration of dopamine in the NAc after exposure to novelty is much 
more increased in HRs than in LRs199,202. Therefore in this study we have 
tested whether this also holds true for APO-SUS and APO-UNSUS rats, 
using the microdialysis technique to measure extracellular levels of 
accumbal dopamine. 
We have recently found that APO-SUS and APO-UNSUS rats differ in the 
catecholaminergic innervation of the NAc, using tyrosine hydroxylase (TH) 
immunocytochemistry. Naive APO-SUS rats have a more extensive fibre 
network and more varicosities in the NAc than APO-UNSUS rats234. If 
dopamine release in the NAc is involved in the differential response to 
novelty of these two types of rats, this might also be accompanied by 
changes in the dopaminergic innervation of the NAc. Therefore we used an 
antibody against TH, which is the rate-limiting enzyme in the synthesis of 
dopamine and noradrenaline, and quantified the extent of the TH-
immunoreative (TH-IR) fibre network and varicosities in subareas of the 
NAc shell and core separately, since it has been found that the dopaminergic 
innervation differs between these two regions247,256 and since these areas are 
known to be differentially involved in responses to stressors such as novelty. 
The shell, which is innervated by dopaminergic neurons arising primarily 
from the ventral tegmental area, exhibits a stronger dopamine release in 
response to stressors than the core252, which is predominantly innervated by 
dopaminergic neurons arising from the substantia nigra, pars compacta27.   
 
Materials and methods 
Animals  
Male rats of the 30th and 31st generation of the APO-SUS and APO-UNSUS 
rat lines, aged 2.5 months (APO-SUS rats, n=10, APO-UNSUS rats, n=10) 
were used for the microdialysis experiments. Male rats of the same 
generations (APO-SUS rats, n=12, APO-UNSUS rats, n=12), aged 2.5 
months, were used for the immunocytochemical studies. The lines have 
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been bred and reared in the Central Animal Laboratory of the University of 
Nijmegen, and were housed in air humidity-controlled rooms, at 21 ± 2 oC, 
with a 12/12 light/dark cycle (lights on at 07.00). Food and water were 
available ad libitum in the home cages. All experiments were carried out in 
accordance with institutional, national and international guidelines for 
animal care and the Dutch law concerning animal welfare.  
 
Microdialysis experiments 
Surgery  
APO-SUS and APO-UNSUS rats were unilaterally implanted with stainless 
steel guide cannulas (length: 5.5 mm, outer diameter: 0.65 mm, inner 
diameter: 0.3 mm) directed at the right nucleus accumbens according to 
previously described procedures170,202. The rats were transported to the 
operation room 30 min prior to surgery in order to allow for acclimatization. 
Under sodium pentobarbital anaesthesia (60 mg/kg, i.p.) rats were placed in 
a stereotactic apparatus and according to the atlas of Paxinos and Watson178  
the following coordinates were used: anterior: +10.6 mm (relative to the 
interaural line), lateral: +1.5 mm (relative to the midline suture) and vertical: 
-5.5 mm (relative to the dura surface). The cannula was angled 10o laterally 
to the right side and fixed onto the skull with stainless steel screws and 
dental cement. The guide cannula contained an inner cannula to prevent 
infections and occlusions.  
 
Post-operative period and handling 
The rats were individually housed and allowed to recover from surgery for 
the next 7 to 10 days in Plexiglas dialysis cages (25 x 25 x 35 cm), which 
became their 'home cage' for the rest of the experiment. On three consecutive 
days just prior to the start of the microdialysis experiment, each rat was 
gently picked up and lifted above the top of the 'home cage ' in order to 
habituate to the procedure assessed on the day when accumbal dopamine 
was measured. This handling procedure was repeated 3 times per day202.  
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Microdialysis and neurochemical measurements 
One day before the experiment, a dialysis probe (type A-1-8-02, outer 
diameter: 0.22 mm, 50,000-molecular-weight cut-off, Eicom, Tokyo, Japan) 
was carefully inserted into the guide cannula of an awake rat and secured to 
the guide cannula with a screw. The tip of the dialysis probe protruded 2 mm 
below the distal end of the guide cannula into the NAc and was situated in 
both core and shell. The probes had an in vitro recovery of 10-12% for 
dopamine. No corrections were made to measure in vivo recovery because 
these estimations are inaccurate14,15,148. The inlet and outlet of the probe were 
connected to a swivel allowing the rat to move undisturbed.  
Accumbal dialysates were analysed for dopamine (pg/40 μl) according to 
previously described procedures117. Briefly, the probe was perfused at a rate 
of 2.0 μl/min with modified ringer solution and the outflow was collected in 
a sample loop and injected automatically, once every 20 min, into a high 
performance liquid chromatography (HPLC) system. Dopamine was 
separated by means of reversed phase, ion-paring liquid chromatography and 
the concentration was measured using electrochemical detection (ECD) in 
either an HPLC-ECD system of Eicom (type ECD-100, Tokyo, Japan) or 
Antec Leyden (type Decade + LINK, low pass inline noise killer), Leiden, 
The Netherlands). In the Antec system dopamine was separated on a Supelco 
LC-18-DB column (particle size: 5 μm, 4.6 x 250 mm, Zwijndrecht, The 
Netherlands) using a mobile phase containing 8% methanol (flow rate: 800 
μl/min, temp: 35 oC) whereas in the Eicom system an Eicompak CA-50DS 
column (particle size: 5 μm, 4.6 x 150 mm, Eicom, Tokyo, Japan) in 
combination with a mobile phase containing 20% methanol (flow rate: 1 
ml/min, temp: 25 oC) was used. In both systems the working electrode was 
set at + 400 mV against a silver/silver-chloride reference electrode. Each 
HPLC-ECD system was calibrated with a standard dopamine solution before 
and after each experiment. In both systems the accuracy of measurement was 
within 1.6% and the detection limit was about 500 fg per sample (= 40 μl). 
Rats were randomised over the two microdialysis systems.   
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Baseline concentration of dopamine in the NAc 
The extracellular striatal concentration of dopamine is known to reach a 
stable baseline ± 10% 4 hours following probe insertion202,228. As soon as a 
stable baseline concentration of dopamine was reached, 3 consecutive 
samples were taken in order to assess the accumbal extracellular 
concentration of dopamine in fully habituated and otherwise unchallenged 
APO-SUS and APO-UNSUS rats. The mean dopamine concentration of the 
3 baseline samples was used as control value (100%).  
 
Novelty 
Immediately after the third baseline sample was taken, rats were placed in a 
novel cage with larger dimensions (30x30x35 cm) and lacking sawdust and 
the accumbal extracellular concentration of dopamine was recorded for an 
additional period of 3 hours (at 20 min intervals).  
 
Histology 
At the end of each experiment the rats were deeply anaesthetised with an 
overdose of sodium-pentobarbital (120 mg/kg, i.p.) and, after breathing had 
stopped, transcardially perfused with 60 ml 4% paraformaldehyde solution. 
Then they were decapitated, the brains were removed and postfixed in the 
same solution for at least 24 h. Vibratome sections (100 μm, Leica, 
Nussloch, Germany) were cut to determine the exact location of the 
microdialysis probe.      
 
Compounds 
The following compounds and solutions were used during the experiment: 
- Modified ringer solution: 147 mM NaCl, 4 mM KCl, 1.1 mM 
CaCl2.2H2O and 1.1 mM MgCl2.6H2O were dissolved in ultrapure water 
(pH 6.0). All chemicals were purchased from Sigma (St Louis, USA). 
- Mobile phase (Eicom system): 0.1 M sodium phosphate buffer 
(NaH2PO4.2H2O : Na2HPO4. 12H2O, ratio 25:8; Wako, Osaka, Japan), 
3.1 mM sodium 1-octanesulphonate (Nacalai Tesque, Kyoto, Japan) and 
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0.1 mM di-sodium EDTA (Dojindo, Kyoto, Japan) were dissolved in 
ultrapure water containing 20% methanol (LabScan, Dublin, Ireland). 
- Mobile phase (decade system): 10.4 mM citric acid (Acros, Geel, 
Belgium), 6.1 mM sodium acetic acid (Acros), 2.35 mM sodium nitrate 
(Acros), 1.85 mM sodium 1-heptanesulfonic acid (Sigma) and 0.3 mM 
di-sodium EDTA (Janssen, Beerse, Belgium) were dissolved in ultra 
pure water containing 8% methanol (LabScan).  
- Dopamine standard solutions: for the Eicom system 50 pg dopamine 
(Sigma) was dissolved in 0.1 M HCl solution (Boom, Meppel, The 
Netherlands) and for the Decade system 5 pg dopamine (Sigma) was 
dissolved in 25 mM acetic acid solution (Sigma). 
- Sodium pentobarbital 60 mg/ml: Narcovet®: Apharma, Arnhem, The 
Netherlands.  
- Paraformaldehyde 4% solution: Merck, Darmstadt, Germany. 
 
Statistical analysis 
The baseline concentration of accumbal dopamine (pg/sample = pg/40 μl) in 
habituated and untreated rats is expressed as the mean dopamine 
concentration of the three consecutive '20 min lasting samples' taken 1 h 
immediately before exposure to novelty. The accumbal dopamine levels 
measured during 3 hours after novelty are expressed as a percentage of the 
baseline concentration of dopamine. All data are expressed as the mean of all 
rats per treatment group ± SEM.  
To statistically evaluate the neurochemical differences in the baseline 
extracellular levels of accumbal dopamine data of the APO-SUS and the 
APO-UNSUS rats were subjected to a one-way ANOVA.  
The neurochemical effects of novelty were analysed by a two-way 
ANOVA with repeated measures with the factors time and ratline. To 
evaluate whether the extracellular amount of dopamine was above 
baseline, a one-sample t-test was performed per rat line with a 
reference value of 100. A probability level of P<0.05 was taken as 
significant in every test. SPSS 10.0 (SPSS Inc., Chicago, Il, USA) was 
used to statistically analyse the data.  
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Immunocytochemical experiments 
Experimental set-up 
Two groups, each consisting of 6 APO-SUS and 6 APO-UNSUS rats, were 
treated as follows.  
Group A. Control rats. Animals were housed individually in their home 
room for 12 days, in Plexiglas cages (25 x 25 x 35 cm) with the floor 
covered with ca. 3 cm sawdust, and handled three times a day during days 
7, 8 and 9, as described above. On day 10 they were habituated in an 
experimental room for 30 min, and afterwards returned to the home room 
for 48 hours.  
Group B. Novelty-challenged rats. The rats were treated in exactly the same 
way as the animals in group A (see above) during the first 9 days. On day 
10 they were habituated in an experimental room for 30 min, after which 
the novelty stressor was applied as described above. After 1.5 hrs, they were 
returned to their home cages in the home room for 48 hrs. This novelty 
procedure was chosen in view of the fact that this novelty stressor has been 
found to increase the release of dopamine in the NAc of HRs, which are rats 
that share many features with APO-SUS rats 202. 
Tissue processing 
After treatment, rats were deeply anaesthetised by intraperitoneal 
administration of sodium pentobarbital (120 mg/kg, i.p.), and transcardially 
perfused with 50 ml 0.9% NaCl in distilled water, followed by 300 ml 4% 
paraformaldehyde in 0.1 M sodium phosphate-buffered saline (PBS; pH 
7.3). Then, brains were removed and postfixed in the same fixative, for 16 
hrs at 4 oC. Coronal vibratome (Leica, Nussloch, Germany) sections (50 
μm) containing the NAc, were rinsed in PBS and in 0.3% H2O2 in PBS. 
Subsequently, sections were pretreated with PBS containing 0.1% BSA and 
0.3% Triton-X-100 for 30 min, and then incubated with anti-TH serum 
(1:20,000; Diasorin, Stillwater, MN, USA) for 16 hrs. After rinsing, 
sections were incubated in goat-anti-mouse (1:1,500, Vector Laboratories, 
Burlingame, Canada) for 90 min, rinsed, incubated with avidin-biotin 
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conjugate (Vector ABC Elite, Vector Laboratories, Burlingame, California) 
for 90 min. After ABC incubation and rinsing, sections were treated with 
0.025% 3’3’-diaminobenzidine containing 0.15% nickel ammonium 
sulphate for 10 min. Subsequently the immunostaining was developed by 
treating the sections with the former solution containing 0.00015% H2O2, 
for 10 min, and rinsed. Serial sections were mounted on poly-L-lysine-
coated slides, dehydrated and coverslipped with Entellan®. Sections per rat 
line and treatment group were divided at random per staining session. 
 
Morphometry  
Morphometry of the TH-IR fibre network was carried out in the NAc, in the 
section approximately -1.7 mm from Bregma (Interaural 10.70 mm) 
according to Paxinos and Watson178. For quantification in the core, a 
sampling area centrally between the anterior commissure and the lateral 
ventricle was taken. For the shell, a vertical line from the lateral ventricle 
and a horizontal line from the middle of the anterior commissure were 
drawn. These lines represented the dorsal and lateral border of the sampling 
area. (see Fig. 1). Morphometry was carried out using a Nikon light 
microscope (Nikon, Tokyo, Japan) with an eyepiece graticule, at a final 
magnification of x1,000. The total length of the TH-IR fibres in the 
sampling area (‘extent’ of the fibres) was quantified by direct line-
intersection counting. The extent of the fibre network (l), expressed in 
μm/100 μm2, was calculated according to the formula of Loud et al.150: l = 
(πc/2d) x (M/1000), in which c is the number of intersections of the fibres 
with the graticule lines, d is the distance measured along the grid lines, and 
M is the magnification. The numerical density of varicosities was expressed 
as number/1,000 μm2. All morphometric procedures were performed as a 
blind study. 
Photomicrographs were made on a Zeiss Axiovert 135 TV microscope 
(Zeiss, Göttingen, Germany) equipped with a Coolsnap fx digital camera 
(Roper Scientific, Tucson, USA). 
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Fig 1. The grey squares indicate the sampling areas for the NAc core and shell. 
(Coordinates according to Paxinos and Watson178). 
Cpu = caudate-putamen, Ac = anterior commissure  
 
Statistical analysis 
To assess the effect of novelty a two-way ANOVA was performed with 
‘treatment’ and ‘rat line’ as independent variables, comparing the data of 
control rats to those of the novelty-challenged rats. Given the fact that the 
core and shell are two distinct areas, which differ both structurally and 
functionally257, the effects of novelty were analysed using a two-way 
ANOVA for core and shell separately, followed by a Student t-test where 
appropriate. Analyses were done using SPSS 10.0 software (SPSS Inc., 
Chicago, Il, USA). Differences were considered significant when P<0.05.   
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Results 
Microdialysis experiments 
Histology 
Histological verification revealed that all placements of the microdialysis 
cannula were made correctly. Figure 2 shows the coronal region of the NAc 
in which all correctly placed microdialysis probe tracks were located. 
 
 
 
Fig 2. Photograph of a unilateral microdialysis probe track located in the 
right nucleus accumbens. The probe protrudes 2 mm below the distal end of 
the guide cannula (fig: 1A). Schematic illustration of coronal brain sections 
containing the nucleus accumbens. The brain region in which correctly 
placed probes were found is indicated as a grey oval (fig: 1B-1D). IA 
corresponds to the distance (mm) from the interaural line according to 
Paxinos and Watson, NAC = nucleus accumbens, CPU = caudate putamen, 
CC = corpus callosum. 
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Baseline extracellular levels of accumbal dopamine between APO-SUS 
and APO-UNSUS rats 
There were no differences between APO-SUS (2.54 ± 0,21 pg/sample) and 
APO-UNSUS rats (2.63 ± 0,36 pg/sample) in basal extracellular 
concentration of dopamine (Fig 3). 
 
Effects of novelty on the extracellular amount of accumbal dopamine in 
APO-SUS and APO-UNSUS rats 
As shown in Fig. 4, novelty increased the concentration of extracellular 
dopamine in time (time effect: F11,198=5,57, P<0.001). More importantly, 
APO-SUS and APO-UNSUS rats reacted differently in time (time x rat line 
effect: F11,198=2.33, P<0.05); whereas the amount of extracellular dopamine 
in APO-SUS rats remained above baseline for 160 min, it declined to 
baseline within 60 min in APO-UNSUS rats (see Fig 4). Furthermore, there 
were significant differences between APO-SUS and APO-UNSUS rats (rat 
line effect: F1,18=4.92, P<0.05).  
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Fig 3. Baseline concentration of extracellular dopamine in the Nucleus Accumbens 
(pg/sample = pg/40 μl) 4 h after probe insertion in unchallenged and untreated 
APO-SUS and APO-UNSUS rats. Values are expressed as mean (± SEM) of the 
dopamine concentration of the three consecutive '20 min lasting samples' taken in a 
period of 1 h immediately before the novelty challenge.  
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Fig 4. The effects of novelty on the extracellular concentration of dopamine in the 
NAc of APO-SUS (◊) and APO-UNSUS (o) rats. Values are accumbal dopamine 
levels expressed as percentage of baseline accumbal dopamine levels on different 
time-points after novelty. Data are expressed as mean percentage ± SEM. The 
dotted line represents baseline accumbal extracellular concentration of dopamine. 
Filled symbols (♦, •) indicate significant differences compared to baseline (one-
sample t-test).  
 
 
Immunocytochemical experiments 
General morphological characteristics 
The NAc of APO-SUS and APO-UNSUS rats consists of unstained cell 
bodies and numerous TH-IR fibres. The TH-IR fibres and varicosities were 
strongly stained, making them stand out clearly and sharply against the 
unstained background (Fig. 5a, c-h). This picture held for both the core and 
the shell subareas of the NAc in all experimental groups. No positive 
staining was observed when the first antiserum had been omitted.  
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Figure 5. TH-immunoreactive staining of the nucleus accumbens. (A)
Photograph of TH-immunoreactive staining in the NAc. (B) Magnification of
(A), in which the delineation between core and shell clearly can be observed
(ac = anterior commissure). (C) Example of TH-immunoreactive varicosities
in the NAc.  
The effect of novelty  
SHELL 
Fibre extent (Fig. 6a). With respect to the extent of the fibre network in the 
shell subarea, an interaction between rat line and treatment was found (two-
way ANOVA: F3.20= 5.5, P<0.05): novelty increased this parameter 
especially in APO-SUS rats (t-test: t1,10=2.5, P<0.05), whereas it had no 
effect on APO-UNSUS rats. No effect of rat line and no effect of novelty 
were found. 
Varicosities (Fig. 6b). Different results were obtained for the number of 
varicosities. In the shell, significant differences between rat lines were 
found (F3,20=26.5, P<0.01): the shell of APO-SUS rats contained more 
varicosities than the shell of APO-UNSUS rats. No effect of novelty and no 
interaction between rat line and treatment were found. 
 
 
 
CORE  
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Fibre extent (Fig. 7a). In the core subarea a significant effect of novelty was 
found (F3.20=6.6, P<0.05): novelty increased the fibre extent. No differences 
between rat lines and no interaction between rat line and treatment was 
found. 
Varicosities (Fig. 7b). In the core subarea, significant differences 
were found between rat lines (F3.20=15.3, P<0.01): the number of 
varicosities was higher in APO-SUS than in APO-UNSUS rats. No 
effect of novelty and no interaction between rat line and treatment 
were found.   
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Fig 6 
The effect of novelty on the 
extent of the fibre network 
in the shell of the nucleus 
accumbens, expressed as 
mean ± S.E.M. 
Rat line x treatment F3,20=5.5 
P<0.05 
The effect of novelty on the 
numerical density of 
varicosities in the shell of 
the nucleus accumbens, 
expressed as mean ± 
S.E.M. 
Rat line F3,20=26.5 P<0.01 
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Fig 7 
The effect of novelty on the 
extent of the fibre network 
in the core of the nucleus 
accumbens, expressed as 
mean ± S.E.M. 
Treatment F3,20=6.6 P<0.05 
 
Varicosities core
0,0
10,0
20,0
30,0
40,0
50,0
60,0
70,0
80,0
APO-SUS APO-UNSUS
# 
va
ric
os
itie
s/
10
00
 s
qu
ar
e 
m
ic
ro
n
control
novelty
 
The effect of novelty on the 
numerical density of 
varicosities in the core of 
the nucleus accumbens, 
expressed as mean ± 
S.E.M. 
Rat line F3,20=15.3 P<0.01 
 
 
Discussion 
Methodological considerations 
We used immunocytochemistry for the enzyme TH to delineate the 
catecholaminergic network in the NAc. Although TH is the rate-limiting 
enzyme in the synthesis of both dopamine and noradrenaline, it is unlikely 
that the changes observed are due to changes in noradrenergic fibres, 
because the vast majority of fibres innervating the NAc are dopaminergic. 
The minority of fibres that are noradrenergic innervate the NAc at a more 
caudal level than where the measurements in this study were carried out18. 
However, the role of noradrenaline remains to be investigated. 
We have chosen to limit measurements to subareas within the core and shell 
for reasons described in our previous report. In short, these subareas were 
chosen because they appear to represent specific functional subdomains in 
the shell and core regions of the NAc132,227. 
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Finally, the TH-IR varicosities appear at the light microscopical level as 
swellings of axonal processes. Although light-microscopically it is not 
possible to determine the exact nature of these swellings, it can be assumed, 
on the basis of ultrastructural data on the presence of TH in the rat brain, that 
some of the varicosities are sites in which neurotransmitter vesicles are being 
stored. However, the majority of varicosities represent presynaptic release 
sites for dopamine or noradrenaline101,207,247.  
  
Basal differences between APO-SUS and APO-UNSUS rats 
The number of varicosities in both shell and core subarea was larger in APO-
SUS than in APO-UNSUS rats. This is in agreement with our previous 
report234.  
In the microdialysis experiments, however, we found no differences in basal 
extracellular concentration of dopamine between APO-SUS and APO-
UNSUS rats. In general, non-quantitative microdialysis, as was used in this 
study, is unable to detect subtle differences113,199. Therefore, basal 
differences between APO-SUS and APO-UNSUS rats in the concentration 
of extracellular dopamine might be present, but could not be detected. It has 
been shown that with this microdialysis technique such small differences 
can only be observed when the number of animals is expanded up to 40 per 
group (Verheij et al., unpub). 
 
Effects of novelty on APO-SUS and APO-UNSUS rats 
Our data show that the dopaminergic response to novelty differed both in 
intensity and in duration between APO-SUS and APO-UNSUS rats; 
namely, APO-SUS rats had a larger and longer-lasting increase in 
extracellular levels of dopamine than APO-UNSUS rats. This corresponds 
with previously reported findings that HRs, which resemble APO-SUS rats 
in many respects, reveal a stronger increase in the extracellular 
concentration of dopamine in the NAc after novelty than LRs, which 
resemble APO-UNSUS rats202. Furthermore, we show that novelty 
increased the TH-IR fibre network in the shell subarea of APO-SUS rats, 
but not in APO-UNSUS rats. The finding that the extent of the TH-IR fibre 
network was not at all increased in the shell subarea of APO-UNSUS rats 
after novelty, whereas microdialysis revealed that the extracellular 
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concentration of dopamine was increased, must be seen in the light of the 
fact that the two procedures were performed at different periods. Thus, 
whereas the microdialysis was done immediately following the exposure to 
novelty, the TH analysis was done 48 hours later. 
The question therefore arises why placement of a rat in a novel environment 
for only 1,5 hours can increase the extent of the TH-IR fibre network 48 
hours after the manipulation. An explanation for this finding is that the 
measured increase in dopamine release after exposure to novelty depletes 
the nerve terminal of dopamine. This depletion, in turn, is hypothesised to 
stimulate the recruitment of TH, causing an increase in the number of 
visible TH-containing fibres. This might also explain the stronger increase 
in TH-IR in the shell subarea of APO-SUS rats, since these rats showed a 
longer-lasting increase in the extracellular concentration of dopamine than 
APO-UNSUS rats.  
An alternative explanation for the increase of the TH-IR network, namely 
the possibility of morphological plasticity, i.e. the outgrowth of fibres after 
an environmental stimulus, cannot be ruled out. Morphological plasticity 
has been described following repeated administration of drugs, or after 
long-term environmental changes such as enriched environment housing of 
the animals over longer periods of time134,135,193,194. However, to our 
knowledge there is no evidence that a mild stimulus such as novelty can 
induce morphological changes in a time period of 48 hours. 
In the microdialysis experiments we did not make a distinction between 
core and shell: the probe track was situated in both the core and the shell 
(Fig 2). On the basis of TH-immunocytochemistry it was observed that the 
differences in the response to novelty between APO-SUS and APO-UNSUS 
rats occurred only in the shell and not in the core subarea. This is not 
surprising, because several studies have indicated that especially the shell is 
involved in responses to stress, whereas the core is more involved in the 
control of voluntary movements12,71,74,252. Based on these TH-IR data it can 
be assumed that the changes in the extracellular concentration of dopamine 
in the NAc found in the present study are primarily due to changes in the 
shell. 
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Surprisingly, exposure to novelty also had a line-independent effect in the 
core subarea: it enhanced the fibre extent without altering the number of 
varicosities in both rat lines. Given the fact that studies have shown that the 
shell but not the core, is involved in the response to mild stressors252, the 
observed changes in the core subarea are difficult to explain. However, the 
core of the NAc is not completely devoid of terminals arising from 
dopaminergic mesolimbic cell bodies in the ventral tegmental area, that 
primarily project to the shell173. It may therefore be speculated that the 
novelty-induced increase in the extent of the fibre network in the core is due 
to novelty-induced changes in these mesolimbic fibres.  
 
Overall conclusion 
In sum, we have demonstrated that, compared to APO-UNSUS rats, APO-
SUS rats have a stronger and longer-lasting increase of extracellular 
concentrations of dopamine in the NAc after exposure to novelty. In 
addition, APO-SUS, but not APO-UNSUS rats responded with an increase 
in the extent TH-IR network in the NAc shell when measured 48 hours after 
novelty. In the core, both APO-SUS and APO-UNSUS rats showed an 
increase in the TH-IR fibre network. The results of this study confirm earlier 
reports that APO-SUS rats are more sensitive to environmental stressors than 
APO-UNSUS rats. Interestingly, these animals also differ in their sensitivity 
to drugs of abuse (see Introduction), which are known to affect the dopamine 
transmission in the NAc31. The present finding that APO-SUS and APO-
UNSUS rats differ in the reactivity of the dopaminergic system provides a 
solid basis for studying the cellular mechanisms of such drugs.  
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Abstract 
Studies using rats have found that animals that are relatively stress-sensitive 
are more prone to addictive drugs such as cocaine than animals that are 
relatively stress-resistant. The underlying neuronal mechanism for this 
individual variablity is not fully elucidated.  
In this study we used apomorphine-susceptible and apomorphine-
unsusceptible rats as an animal model for individual differences in stress-
responsivity and self-administration of cocaine. Apomorphine-susceptible 
rats are more stress-responsive and self-administer more cocaine than 
apomporphine-unsusceptible rats. Cocaine was administered twice with a 
72 hours interval (10 mg/kg, i.p.) and the effects were studied in several 
subareas of the nucleus accumbens, medial prefrontal cortex, ventral 
tegmental area and substantia nigra using immunocytochemistry for the 
enzyme tyrosine hydroxylase. Additionally, we studied the effects of 
cocaine in the medial prefrontal cortex of these animals using 
immunocytochemistry for the enzyme dopamine-beta-hydroxylase. 
The cocaine-induced increase in tyrosine hydroxylase-immunoreactive cell 
bodies in the ventral tegmental area and substantia nigra, pars compacta was 
similar in both types of rat. In contrast, cocaine increased the amount of 
tyrosine hydroxylase-immunoreactive varicosities in most subareas of the 
nucleus accumbens of apomorphine-unsusceptible rats, but not in that of 
apomorphine-susceptible rats. In addition, cocaine increased the amount of 
tyrosine hydroxylase-immunoreactive varicosities in several subareas of the 
medial prefrontal cortex of apomorphine-susceptible rats, but decreased this 
in several subareas of the medial prefrontal cortex of apomorphine-
unsusceptible rats. Cocaine had only a marginal effect on the number of 
dopamine-beta-hydroxylase-immunoreactive varicosities in the medial 
prefrontal cortex. 
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Introduction 
The different vulnerability of individuals to become drug addicts is a 
puzzling phenomenon. Although many individuals have experimented with 
a variety of drugs, only few of them become actually addicted. The ability 
to become addicted is present not only in man, but also in laboratory 
animals and, like humans, they also display individual differences in the 
vulnerability to develop addictive behaviour. There are several behavioural 
and neurochemical features that are associated with these differences in 
vulnerability. Numerous studies using rat models for individual differences 
have shown that an increased vulnerability to an addictive drug such as 
cocaine is associated with a higher stress-responsiveness, measured both 
behaviourally and at the level of the hypothalamic-pituitary-adrenal 
axis56,67,110,113,198. In addition, a correlation has been shown between an 
increased vulnerability and a higher (re)activity of the dopaminergic 
system110,151.  
Several years ago we have developed an animal model for individual 
differences, among others in stress-sensitivity, cocaine-selfadministration 
and the reactivity of the dopaminergic system, namely the apomorphine-
susceptible (APO-SUS) and apomorphine-unsusceptible (APO-UNSUS) rat 
line54,235,238. We selected these rats, because all their behavioural, 
endocrinological and neuropharmacological features are idiosyncratic, 
implying that all their type-specific features are coupled to each other. This 
has the factual advantage that there is no need to analyze each distinct 
feature every time when an experiment is performed. APO-SUS and APO-
UNSUS rats differ in behavioural, neurochemical, physiological and 
endocrinological features. First, compared to APO-UNSUS rats, APO-SUS 
rats show a stronger response to novelty: locomotor activity is much higher 
in APO-SUS rats when placed on an open field54. In addition, APO-SUS 
rats have higher and more prolonged levels of corticosterone and ACTH 
after exposure to novelty than APO-UNSUS rats197. Moreover, APO-SUS 
rats respond stronger to the direct dopamine D1/D2 agonist apomorphine 
and the indirect agonists amphetamine and cocaine54,82,82(Van der Elst et al. 
submitted).  
At the neurochemical level there are pronounced differences in the 
dopaminergic system between APO-SUS and APO-UNSUS rats. For 
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instance, the number of striatal D2/D3 receptor binding sites and D1 
receptor mRNA levels are higher in APO-SUS rats than in APO-UNSUS 
rats196. In addition, tyrosine hydroxylase (TH) mRNA levels are higher in 
the substantia nigra (SN) of APO-SUS rats than in that of APO-UNSUS 
rats196. More recently, it has been found that APO-SUS rats have higher 
levels of TH-immunoreactivity (TH-IR) in the NAc under basal conditions, 
suggesting that APO-SUS rats have a higher basal synthesis and, possibly, a 
higher basal release of dopamine234. In addition, APO-SUS rats have a 
higher and more prolonged dopamine release after exposure to novelty235. 
The aim of this study was to investigate whether the dopamine transporter 
(DAT) blocker cocaine also has a differential effect on the 
catecholaminergic mesolimbic and mesocortical networks in animals with 
the abovementioned pre-existing differences in the dopaminergic systems, 
for such differences might quite well contribute to the differential 
responsiveness to cocaine in these animals. Toward this end, rats from the 
APO-SUS and APO-UNSUS rat lines were treated twice with cocaine and 
the numerical density of TH-IR varicosities was quantified in several 
subdivisions of the NAc and mPFC. The density of TH-IR cell bodies was 
assessed in the substantia nigra, pars compacta (SNc) and ventral tegmental 
area (VTA). Since TH is not only responsible for the synthesis of dopamine, 
but also of noradrenaline (which is converted from dopamine by the enzyme 
dopamine-beta-hydroxylase, DBH92 and because noradrenaline is abundant 
in the mPFC209, we also used immunocytochemistry for DBH in the mPFC. 
Several studies investigating the effects of (chronic or acute) administration 
of cocaine on TH, using a number of different techniques, have yielded 
conflicting results5,118,146,213,227. Numerous factors could have contributed to 
the seemingly contradictory results found in the abovementioned papers, 
such as the method used to measure TH, the rat strains used, the dose, route 
and time schedule of cocaine administration and the possible differences in 
the sampling areas that were chosen within the brain structures. In the 
present study we chose sampling areas in subdivisions of all brain structures 
under study. We have chosen six different subdivisions in the NAc (the 
vertex, arch, cone, intermediate and ventrolateral parts of the shell and the 
core as a whole), according to the method used by Todtenkopf and Stellar, 
because they found that TH was increased in some, but not all subdivisions 
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after repeated administration of cocaine227. The mPFC was subdivided in 
the prelimbic (PrL) and infralimbic (IL) cortex, because subarea-specific 
lesions of the PrL block cocaine-induced sensitization and conditioned 
place preference, whereas IL lesions do not231,232. Furthermore, sampling 
areas in the PrL and IL were chosen in all layers separately, except for the 
layers 2 and 3. These two layers were taken together due to the fact that 
they are very difficult to distinguish from each other. Quantification in the 
different layers was carried out since the distribution of dopamine and 
noradrenaline differs among the layers; whereas dopamine is primarily 
present in the deeper layers, noradrenaline is more abundant in the 
superficial layers20,169. For the VTA, sampling was carried out in four 
different subdivisions: the parabrachial and paranigral area and the lateral 
and medial parts in the middle. There are indications that the distribution of 
TH immunoreactivity differs throughout these areas of the VTA90,216. In 
addition, it is known that the nucleus parabrachialis of the VTA projects 
primarily to cortical areas, including the mPFC, whereas the nucleus 
paranigralis of the VTA projects mainly to subcortical areas including the 
NAc16,149,216. However, there are no clear indications of a functional 
relevance to the distinction between those areas. Therefore, it is interesting 
to study whether cocaine-induced changes in TH might differ between the 
subdivisions of the VTA. The SNc was subdivided into the lateral and 
medial part. Again, to our knowledge the functional relevance has not been 
investigated yet, but it is known that some of the dopaminergic cells in the 
medial part of the SNc project to the NAc and mPFC, whereas no cells of 
the lateral part projects to these areas90.  
 
Material and Methods 
Animals  
Male rats of the 18th generation of the apomorphine-susceptible (APO-SUS) 
rat line and the apomorphine-unsusceptible (APO-UNSUS) rat line 
(replicate lines) were used85. The number of animals per experimental 
groups are given in the figure legends. The lines have been bred and reared 
in the Central Animal Laboratory of the University of Nijmegen, and were 
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housed in air humidity-controlled rooms, at 21 ± 2 oC, with a 12/12 h 
light/dark cycle (lights on at 07.00 am). Food and water were available ad 
libitum in the home cages. All experiments were carried out in accordance 
with institutional, national and international guidelines for animal care and 
the Dutch law concerning animal welfare.  
 
Experimental set-up 
Saline (0.9% sodium chloride) and cocaine (Brocacef, Amsterdam, 
Netherlands) treated APO-SUS and APO-UNSUS rats were individually 
housed in macrolon type III cages (42 x 26 x 20 cm) for 7 days, at 65 +/- 3 
days of age. On day 8 they were placed in an experimental cage with a grid 
floor (37 x 24.5 x 22.5 cm) for 2 hours during 2 consecutive days. On day 11 
they received a saline injection and immediately placed in the experimental 
cages for 2 hrs. On days 12 and 15 the saline groups received a saline 
injection and the cocaine groups received a cocaine injection (10 mg/kg, i.p., 
dissolved in saline), were immediately placed in the experimental cages and 
returned to their home cage after 2 hours. All injections were given in the 
experimental cages because it has been shown that the effects of repeated 
drug administration on both locomotor activation and cellular activation (c-
Fos) are stronger when they are performed in a cage other than the home 
cage177.  
 
Tissue processing 
Rats were deeply anaesthetised by intraperitoneal administration of sodium 
pentobarbital (120 mg/kg, i.p.) 48 hours after the last cocaine injection, and 
transcardially perfused with 50 ml 0.9% sodium chloride (NaCl) in distilled 
water, followed by 300 ml 4% paraformaldehyde in 0.1 M sodium 
phosphate-buffered saline (PBS; pH 7.3). Then, brains were removed and 
postfixed in the same fixative, for 16 hrs at 4 oC. Coronal vibratome (Leica, 
Nussloch, Germany) sections (50 μm) were rinsed in PBS and in 0.3% 
H2O2 in PBS. Subsequently, sections were pretreated with PBS containing 
0.1% bovine serum albumin (BSA) and 0.3% Triton-X-100 for 30 min, and 
then incubated with anti-TH serum (1:20,000; Diasorin, Stillwater, MN, 
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USA) or anti-DBH serum (1:20,000; Diasorin, Stillwater, MN, USA) for 16 
hrs. After rinsing, sections were incubated in donkey-anti-mouse for TH 
and in donkey-anti-rabbit for DBH (1:1,500, Vector Laboratories, 
Burlingame, Canada) for 90 min, rinsed and incubated with avidin-biotin 
conjugate (Vector ABC Elite, Vector Laboratories, Burlingame, California) 
for 90 min. After ABC incubation and rinsing, sections were treated with 
0.025% 3’3’-diaminobenzidine (DAB) containing 0.15% nickel ammonium 
sulphate for 10 min. Subsequently the immunostaining was developed by 
treating the sections with the former solution containing .00015% H2O2, for 
10 min, and rinsed. Serial sections were mounted on gelatine-coated slides, 
dehydrated and coverslipped with Entellan®. 
 
Morphometry 
General 
For quantification, Stereo-Investigator software was used connected to a 
Zeiss Axioskop FS microscope connected to CCD camera (DVC company, 
Austin, Texas, USA). Estimates of the numerical density of varicosities 
(mPFC, NAc) or cell bodies (VTA, SNc)  were made by means of the optical 
fractionator probe. For all areas mentioned below, a fixed distance of 3 μm 
from the upper surface of the section was not quantified, due to the waviness 
of the sections. For every subregion 10 to 15 sampling sites were quantified.  
 
Nucleus accumbens (Fig 1) 
TH-IR varicosities were quantified at the level of the major Island of 
Calleja for the NAc (Interaural 10.20-10.00 mm, according to the atlas of 
Paxinos and Watson178). The NAc shell was subdivided into five 
subregions, according to the method used by Todtenkopf et al.227, based on 
the distribution of TH-IR. The dorsomedial part of the shell was subdivided 
into the vertex (VERT), the arch of the dorsomedial shell (ARCH) and the 
cone of the septal pole (CONE). The VERT and the CONE are separated by 
the ARCH, which is an arch-shaped part of the dorsomedial shell with a 
much weaker TH-IR. Above the ARCH, the VERT is situated, the most 
dorsal part of the shell which lies adjacent to the lateral ventricle. The 
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CONE lies just beneath the ARCH and is characterized by a dense pattern 
of TH-IR.  
The more ventral parts of the shell were subdivided into the intermediate 
zone (INT) and the ventrolateral zone (VL). The INT is situated ventrally to 
the cone and is characterised by a weaker pattern of TH-IR than the CONE. 
The most ventral part of the shell is the VL and this is the part ventrolaterally 
to the anterior commissure and has a dark pattern of TH-IR. The core of the 
NAc was not subdivided, due to its more homogeneous pattern of TH-IR.  
Varicosities were counted in the above-mentioned subregions of the NAc at 
a final magnification of x1000 in a counting frame of 10 μm width, 10 μm 
length and 8 μm depth. Data are expressed as the average number of 
varicosities per 800 μm3.  
  
Medial Prefrontal Cortex (Fig 2) 
The sampling areas in the mPFC were chosen in the layers 1, 5 and 6 
seperately and layers 2 and 3 combined, of the prelimbic (PrL; PrL1, PrL23, 
PrL5 and PrL6) and infralimbic (IF; IF1, IF23, IF5 and IF6) cortices 
(Interaural 12.20-11.70 mm, according to Paxinos and Watson 178.  
Varicosities were counted at a final magnification of x 1000, in a counting 
frame of 10 μm width, 10 μm length and 30 μm depth. We chose the depth 
differently from the NAc because we observed much lesser amounts of 
varicosities in the mPFC compared to the NAc. Data are expressed as mean 
number of varicosities per 3000 μm3. 
 
Ventral Tegmental Area and Substantia Nigra, pars compacta (Fig 3) 
TH-IR cell bodies were quantified in the VTA and SNc (Interaural 3.80-
3.40 mm) 178. For the VTA, we have chosen four different subareas; the 
areas known as the parabrachial and the paranigral area and a lateral and 
medial sampling area in the middle. For the SNc we chose sampling areas 
in the lateral and medial parts.  
Cell bodies were counted at a final magnification of x 200, in a counting 
frame of 50 μm width, 50 μm length and 30 μm depth. Data are expressed 
as mean number of cell bodies per 75000 μm3. 
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Statistical analysis 
First, basal differences between APO-SUS and APO-UNSUS per area were 
analyzed using an independent-samples t-test.  
Second, the data were statistically analyzed by a two-way analysis of 
variance (ANOVA) per area with rat line and treatment as independent 
variables, in order to evaluate differences between APO-SUS and APO-
UNSUS rats in the response to cocaine. A post-hoc t-test was performed 
where appropriate. Data were considered statistically significant when 
P<0.05. SPSS version 10.0 software was used for all analyses (SPSS Inc., 
Chicago, Il, USA).  
 
 
 
 
Fig 1 Schematic drawing of the chosen sampling areas in the nucleus accumbens 
(10.00 mm anterior to Interaural line, according to Paxinos and Watson). 
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Fig 2. Schematic drawing of the PrL and IL parts of the medial prefrontal cortex 
(11.70 mm anterior to Interaural line, according to Paxinos and Watson). In every 
layer a sampling area was chosen. 
 
Fig 3 Schematic drawing of the chosen sampling areas in the ventral tegmental area 
and substantia nigra, pars compacta (3.80 mm anterior to Interaural line, according 
to Paxinos and Watson).  
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Results 
First, we describe basal differences between (saline-treated) APO-SUS 
and APO-UNSUS rats.  
Further, because the primary focus of the present paper was the presence of 
putative differences between APO-SUS and APO-UNSUS rats in response 
to cocaine, we limit the description of the data to the interactions between rat 
line and treatment. Nevertheless, all the F- and P-values of the ANOVA are 
displayed in table I and below we therefore provide only the outcome of the 
post-hoc tests where appropriate.  
 
Basal differences between (saline treated) APO-SUS and APO-UNSUS 
rats 
The density of  TH-IR varicosities in all subareas of the nucleus accumbens 
was significantly higher in APO-SUS rats than in APO-UNSUS rats (VERT: 
t=-3.4, P<0.05; ARCH: t=-4.7, t<0.001; CONE: t=-4.1, P<0.01; INT: t=-2.5, 
P<0.05; VL: t=-2.6, P<0.05; core: t=-4.7, P<0.001). 
In the mPFC there only was a significant difference between APO-SUS and 
APO-UNSUS rats in IL1 (t=3.4, P<0.01). Figure 6 shows that the density of 
TH-IR varicosities in IL1 was higher in APO-UNSUS rats than in APO-SUS 
rats. There were no differences between APO-SUS and APO-UNSUS rats in 
the density of DBH-IR varicosities in the mPFC. 
The density of TH-IR cell bodies in the VTA was higher in APO-UNSUS 
rats than in APO-SUS rats in the PB (t=4.1, P<0.005), but there were no 
differences between the rat lines in the other VTA subareas.  
For the SNc, the density of TH-IR cell bodies was higher in the medial SNc 
of APO-UNSUS rats compared to APO-SUS rats (t=3.5, P<0.05), but there 
were no differences between the two types of rat in the lateral SNc. 
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Structure Subregion Rat line Treatment Interaction 
NAc VERTEX F  1,22=17.4, P<0.001 F1,22=1.35, P=0.26 F  1,22=4.53, P<0.05 
NAc ARCH F  1,22=9.25, P<0.005 F  1,22=6.02, P<0.05 F  1,22=15.31, P<0.001 
NAc CONE F  1,22=5.33, P<0.05 F1,22=2.61, P=0.12 F  1,22=8.37, P<0.01 
NAc INT F1,21=0.00, P=0.99 F1,21=0.65, P=0.76 F  1,21=8.42 P<0.01 
NAc VL F  1,21=4.33, P<0.05 F1,21=0.56, P=0.46 F1,21=1.66, P=0.21 
NAc Core F1,21=1.42, P=0.25 F  1,21=4.39, P<0.05 F  1,21=18.40, P<0.001 
mPFC PrL1 (TH) F  1,21=10.65, P<0.005 F1,21=0.06, P=0.82 F  1,21=26.45, P<0.001 
mPFC PrL23 (TH) F1,21=2.51, P=0.13 F1,21=3.97, P=0.059 F  1,21=15.90, P<0.001 
mPFC PrL5 (TH) F1,21=3.13, P=0.092 F1,21=2.17, P=0.16 F1,21=2.53, P=0.13 
mPFC PrL6 (TH) F  1,21=4.49, P<0.05 F1,21=0.03, P=0.86 F  1,21=13.67, P<0.001 
mPFC IL1 (TH) F  1,21=16.83, P<0.001 F  1,21=4.51, P<0.05 F  1,21=55.55, P<0.001 
mPFC IL23 (TH) F  1,21=7.57, P<0.05 F  1,21=6.37, P<0.05 F  1,21=22.80, P<0.001 
mPFC IL5 (TH) F1,21=0.08, P=0.78 F1,21=0.27, P=0.61 F  1,21=6.50, P<0.05 
mPFC IL6 (TH) F1,21=0.34, P=0.57 F1,21=0.24, P=0.63 F1,21=2.13, P=0.16 
mPFC PrL1 (DBH) F1,24=2.5,  P=0.13 F1,24=0.18, P=0.68 F1,24=0.68, P=0.42 
mPFC PrL23 (DBH) F1,24=0.26, P=0.61 F1,24=1.76, P=0.20 F1,24=0.00, P=0.97 
mPFC PrL5 (DBH) F1,24=0.10, P=0.75 F1,24=1.60, P=0.22 F1,24=1.71, P=0.20 
mPFC PrL6 (DBH) F1,24=0.57, P=0.46 F1,24=0.47, P=0.50 F1,24=0.17, P=0.68 
mPFC IL1 (DBH) F1,24=2.14, P=0.16 F  1,24=6.56, P<0.05 F  1,24=5.46, P<0.05 
mPFC IL23 (DBH) F  1,24=4.67, P<0.05 F1,24=0.30, P=0.59 F  1,24=5.24, P<0.05 
mPFC IL5 (DBH) F1,24=0.08, P=0.78 F1,24=0.01, P=0.91 F1,24=0.23, P=0.64 
mPFC IL6 (DBH) F1,24=1.40, P=0.25 F1,24=0.51, P=0.48 F1,24=0.71, P=0.41 
VTA PB  F  1,17=19.13, P<0.001 F  1,17=23.00, P<0.001 F1,17=2.60, P=0.13 
VTA PN F  1,17=7.17, P<0.05 F  1,17=37.33, P<0.001 F1,17=0.30, P=0.59 
VTA Mid-medial F1,17=1.09, P=0.31 F  1,17=20.44, P<0.001 F1,17=2.40, P=0.14 
VTA Mid-lateral  F1,17=0.33, P=0.57 F  1,17=38.10, P<0.001 F1,17=0.05, P=0.82 
SNc Medial SNc F  1,17=7.27, P<0.05 F  1,17=5.78, P<0.05 F1,17=0.91, P=0.36 
SNc Lateral SNc F1,17=3.66, P=0.07 F1,17=0.71, P=0.41 F1,17=0.47, P=0.50 
 
Table I.  All F and P-values of the ANOVA are provided in this table. 
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Fig 4. (A) Low magnification micrograph (250x) of TH-immunoreactivity in the NAc 
of an untreated APO-UNSUS rat, with indications of the chosen sampling areas. 
ac=anterior commisure, V= ventricle, ICm=major Island of Calleja. (B) Low 
magnification micrograph (250x) of TH-immunoreactivity in the mPFC of an 
untreated APO-SUS rat, with an indication of the chosen sampling areas in the 
different layers. fmi=forceps minor, corpus callosum. (C,D) High magnification 
micrograph (1000x) of TH-immunoreactivity in the ARCH of the nucleus accumbens 
shell of an untreated APO-UNSUS rat (C) and of a cocaine-treated APO-UNSUS rat 
(D). (E) Low magnification micrograph (250x) of TH-immunoreactivity in the 
VTA/SNc complex of an untreated APO-SUS rat with indication of the chosen 
sampling areas. MT=medial terminal nucleus of the accessory optic tract, 
fr=fasciculus retroflexus. (F) High magnification micrograph (1000x) of a TH-IR 
fibre in layer 2/3 of the PrL region of the mPFC of a cocaine-treated APO-SUS rat, 
containing clear varicosities (arrows). (G) High magnification micrograph (1000x) 
of a DBH-IR fibre in layer 2/3 of the PrL region of the mPFC of a cocaine-treated 
APO-SUS rat, containing varicosities (arrows). 
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Nucleus Accumbens – Tyrosine Hydroxylase (Fig 5) 
Significant interactions between rat line and treatment were found with 
respect to almost all parts of the NAc, except the VL. In the VERT (t=-3.3, 
P<0.01), ARCH (t=-4.5, P<0.001), CONE (t=-2.8, P<0.05), INT (t=-2.5, 
P<0.05) and core (t=-5.3, P<0.001) cocaine increased the density of TH-IR 
varicosities in APO-UNSUS rats. In contrast, cocaine had no effect at all on 
the TH-IR varicosities in the NAc of APO-SUS rats. 
A low-magnification micrograph of TH-IR in the NAc is shown in Fig. 4A. 
Higher magnification micrographs of TH-IR are shown in Figs. 4C and 4D, 
demonstrating differences between TH-IR in the ARCH  of a saline-treated 
(4C) and a cocaine-treated (4D) APO-UNSUS rat. 
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Fig 5. The effects of cocaine on the density of TH-IR varicosities in the NAc of APO-
UNSUS (A) and APO-SUS (B) rats, expressed as number of varicosities per 800 μm3 
± SEM.  
* indicate significant differences. APO-UNSUS saline treated: n=7 for the VERTEX 
and ARCH, n=6 for all other areas. APO-UNSUS cocaine treated: n=7 for all 
areas. APO-SUS: n=6 for every group and area.  
Medial Prefrontal Cortex-Tyrosine Hydroxylase (Fig 6) 
Significant interactions between rat line and treatment were found with 
respect to all areas except PrL5 and IL6. Cocaine increased the density of 
TH-IR varicosities in PrL1 of APO-SUS rats (t=-3.6, P<0.01), but decreased 
this in APO-UNSUS rats (t=3.6, P<0.01). In PrL23 cocaine increased the 
density of TH-IR varicosities in APO-SUS rats (t=-3.8, P<0.005), but had no 
significant effects in APO-UNSUS rats. In PrL6 cocaine increased the 
density of TH-IR varicosities in APO-SUS rats (t=-2.3, P<0.05), but 
decreased this in APO-UNSUS rats (t=3.1, P<0.05). The same holds true for 
IL1, where the density of TH-IR varicosities was increased by cocaine in 
APO-SUS rats (t=-7.2, P<0.001), but decreased in APO-UNSUS rats (t=3.5, 
P<0.01). In IL23 cocaine increased the density of TH-IR varicosities in 
APO-SUS rats (t=-5.6, P<0.001), but had no effect on APO-UNSUS rats. 
Although the post-hoc test showed no significant differences with respect to 
IL5, an interaction between rat line and treatment was found.   
A low-magnification micrograph of TH-IR in the mPFC is shown in Fig. 4B 
and a high-magnification micrograph is shown in Fig. 4F. 
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Fig 6. The effects of cocaine on the density of TH-IR varicosities in the mPFC of 
APO-UNSUS (A) and APO-SUS (B) rats. Data are expressed as number of 
varicosities per 3000 μm3 ± SEM. * indicate significant differences. APO-UNSUS 
saline treated: n=7 for every area. APO-UNSUS cocaine treated: n=7 for every 
area. APO-SUS: n=6 for every group/area.   
Medial Prefrontal Cortex-Dopamine-Beta-Hydroxylase (Fig 7) 
Cocaine had very little effect on the density of DBH-IR varicosities. 
Significant interactions were only found in in IL1 and IL23: in IL1 the 
density of DBH-IR varicosities was decreased in APO-SUS rats (t=4.1, 
P<0.001) by cocaine, whereas it was unaltered in APO-UNSUS rats. In IL23 
no significant post-hoc effects were found. 
A micrograph of a DBH-IR fibre containing varicosities is shown in Fig. 4G. 
# 
va
ric
o
 
si
tie
s
saline
cocaine
*
*
* *
*
B
 74
Chapter 4                                                             Cocaine induced changes TH /DBH            
                                                                          
  
 
 
 
 
 
 
Varicosities APO-UNSUS
mPFC-DBH
0.00
0.50
1.00
1.50
2.00
2.50
PrL1 PrL23 PrL5 PrL6 IL1 IL23 IL5 IL6
# 
va
ric
os
itie
s
saline
cocaine
A 
 
 
 
 
 
 
Varicosities APO-SUS
mPFC-DBH
0.00
0.50
1.00
1.50
2.00
2.50
PrL1 PrL23 PrL5 PrL6 IL1 IL23 IL5 IL6
# 
va
ric
os
itie
s
saline
cocaine
B 
*
Fig 7. The effects of cocaine on the density of DBH-IR varicosities in the mPFC of 
APO-UNSUS (A) and APO-SUS (B) rats, expressed as number of varicosities per 
3000 μm3 ± SEM. * indicate significant differences. APO-UNSUS: n=6 for every 
group/area. APO-SUS: n=8 for every group/area. 
Ventral Tegmental Area and Substantia Nigra, pars compacta – Tyrosine 
Hydroxylase (Fig 8) 
No significant interactions were found with respect to any of the areas 
studied. Considering the PB and PN of the VTA, significant rat line and 
treatment effects were found, whereas only a significant treatment effect was 
found with respect to the medial and lateral parts of the mid VTA (see table 
I). Cocaine increased the density of TH-IR cell bodies in all these areas, but 
this increase was not different between APO-SUS and APO-UNSUS rats. 
With respect to the medial part of the SNc, significant rat line and treatment 
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effects were found. Cocaine increased the density of TH-IR cell bodies in 
both rat lines. 
No significant effects were found with respect to the lateral part of the SNc.  
A micrograph of TH-IR in the VTA/SNc is shown in Fig. 4E. 
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Fig 8. The effects of cocaine on the density of TH-IR cell bodies in the VTA and SNc 
of APO-UNSUS (A) and APO-SUS rats. Data are expressed as the number of TH-IR 
cell bodies per 75000 μm3 ± SEM. APO-UNSUS saline treated: n=5 for every area, 
APO-UNSUS cocaine treated: n=6 for every area. APO-SUS: n=5 for every group 
and area. 
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NAc Vert Arch Cone Intermediate VL core 
APO-SUS = = = = = = 
APO-
UNSUS 
↑ ↑ ↑ ↑ = ↑ 
A 
mPFC PrL1 PrL23 PrL5 PrL6 IL1 IL23 IL5 IL6 
APO-SUS ↑ ↑ = ↑ ↑ ↑ = = 
APO-
UNSUS 
↓ = = ↓ ↓ = = = 
B 
VTA/SNc VTAS-B VTA-PN VTA-
mid-med 
VTA-
mid-
lateral 
SNc-
medial 
SNc-
lateral 
APO-SUS 
and APO-
UNSUS 
↑ ↑ ↑ ↑ ↑ = 
C 
Table II Schematic overview of the effects of cocaine on TH-immunoreactivity in the 
NAc, mPFC, VTA and SNc in APO-SUS and APO-UNSUS rats. =  reflects no 
change, ↑ reflects an increase, ↓ reflects a decrease in TH-IR following cocaine 
treatment. 
 
 
Discussion 
The present study shows that cocaine had a similar effect on the 
dopaminergic cell body areas, the VTA and  SNc, but had a differential 
effect on the terminal areas (mPFC and NAc) in APO-SUS and APO-
UNSUS rats. Cocaine increased the number of TH-IR cell bodies in all 
subareas of the VTA and the medial part of the SNc of APO-SUS and APO-
UNSUS rats. In APO-UNSUS rats, cocaine increased the density of TH-IR 
varicosities in all subareas of the NAc, except in the ventolateral part, but 
had no effect on any of the subareas of the NAc of APO-SUS rats. On the 
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other hand, cocaine increased the density of TH-IR varicosities in some 
subareas of the mPFC of APO-SUS rats, but caused the opposite effect in 
some subareas of the mPFC of APO-UNSUS rats. Finally, cocaine had only 
very little effect on DBH: it decreased the density of DBH-IR varicosities in 
APO-SUS rats, but only in the IL1. 
 
Methodological considerations 
We used immunocytochemistry for the enzymes TH and DBH to assess the 
effects of cocaine. Since TH is the rate-limiting enzyme in the synthesis of 
both dopamine and noradrenaline, the effects of cocaine on TH cannot be 
discussed only in relation to dopamine92. However, in the NAc, dopamine is 
much more abundant than noradrenaline44. In addition, noradrenaline is 
present at a more caudal level than where TH was quantified in the present 
study18. Therefore, we discuss the data on the NAc with focus on dopamine, 
although it cannot be completely excluded that a small portion of the TH-IR 
varicosities is noradrenergic. For the cell bodies in the SNc/VTA complex, 
it is clear that changes observed in TH-IR are dopaminergic: noradrenaline-
containing cell bodies are not present in these areas.  
In the mPFC, noradrenaline is more abundant than dopamine209. Therefore, 
we assessed both TH and DBH in the mPFC in sections from the same 
animals. However, it is known that antibodies against TH primarily (90-
92%) label dopaminergic as opposed to noradrenergic axons in the 
mPFC165. This apparent absence of TH in noradrenergic axons is intriguing, 
but does not imply that TH is not the rate-limiting enzyme in noradrenaline 
synthesis. Several suggestions have been made in order to explain this 
absence. First, noradrenergic axons in the mPFC may contain less TH than 
dopaminergic axons in this region, implying that the detection level is just 
too low87. Second, noradrenergic axons in the mPFC have the ability to take 
up dopamine from the synaptic cleft via the noradrenaline transporter 
(NET) and this dopamine is then converted to noradrenaline222,253. Thirdly, 
it is possible that the sparse TH-IR reflects a low activity state of the 
noradrenergic neurons165. Finally, it is possible that the TH antibodies do 
not recognize TH in noradrenergic neurons, due to variations in the TH 
molecule itself3,120. Thus, although TH primarily labels dopaminergic axons 
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in the mPFC, it is possible that some of the cocaine-induced changes may 
be due to alterations in noradrenergic axons.  
Finally, whereas TH is a rate-limiting enzyme, this does not apply to 
DBH92. Thus, changes in noradrenaline are not necessarily reflected in 
alterations in DBH. 
 
Differences between APO-SUS and APO-UNSUS rats in the cocaine-
induced effects in the nucleus accumbens  
First, we observed that the NAc of APO-SUS rats contained a higher 
numerical density of TH-IR varicosities than that of APO-UNSUS rats, 
confirming an earlier study showing similar differences between these rats 
234. 
Second, the data from this study show that cocaine induced a widespread 
increase in TH-IR in all parts of the NAc in APO-UNSUS rats, except in the 
ventrolateral part of the shell, whereas Todtenkopf et al. have found that the 
cocaine-induced increase in TH-IR was limited to some subdivisions of the 
NAc227. In this context it is relevant to note that we used a schedule of 
cocaine administration that differed from that of Todtenkopf et al.: they 
administered 15 mg/kg cocaine twice daily for 5 consecutive days, whereas 
we administered 10 mg/kg cocaine twice with a 72 hours interval. It is 
known that continuous administration can cause tolerance130, whereas 
intermittent administration of cocaine can produce behavioural 
sensitization. In view of these data, it is possible that our experimental 
paradigm led to sensitization that in turn produced a more widespread effect 
than the experimental paradigm used by Todtenkopf et al. produced. In any 
case, these data again underline the fact that one must carefully keep in 
mind the experimental procedures and the rat strains used when comparing 
data from different studies. 
We also found an increase in TH-IR in the core of the NAc. This is in 
agreement with the outcome of earlier published studies31,142,186,260. 
Finally, it is striking that while cocaine induced such a widespread increase 
in TH-IR in the NAc of APO-UNSUS rats, it had no effect in APO-SUS rats.  
A possible explanation for the differential effects of cocaine in APO-SUS 
and APO-UNSUS rats might be related to the differences in basal TH levels. 
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Since APO-SUS rats have a higher basal level of TH in the NAc (and thus 
presumably a higher dopamine synthesis, as TH is the rate-limiting enzyme) 
it can be hypothesized that the intracellular dopamine concentration is less 
dependent on re-uptake in these rats. Conversely, since the basal TH level 
(and presumably the basal dopamine synthesis) is lower in APO-UNSUS 
rats, these animals will be more dependent on re-uptake. After 
administration of cocaine, which primary action is blocking the dopamine 
transporter (DAT), dopamine cannot be taken up, leading to a decrease in 
intracellular levels of dopamine. Reasoning along the line that APO-UNSUS 
rats would be more dependent on reuptake than APO-SUS rats, the 
intracellular depletion of dopamine in the former rats is greater, leading to an 
upregulation of dopamine synthesis and thus to an upregulation in TH in 
APO-UNSUS rats.   
Differences between APO-SUS and APO-UNSUS rats in the cocaine-
induced effects in the medial prefrontal cortex  
We have shown that cocaine increased TH-IR in several parts of the mPFC 
of APO-SUS rats, but decreased TH-IR in several parts of the mPFC of 
APO-UNSUS rats. Up till now,  the mesocortical dopaminergic system has 
not been investigated in the APO-SUS and APO-UNSUS rats. However, 
there is a well known reciprocal relationship between the cortical and 
subcortical dopaminergic system. For example, a decreased dopamine 
transmission in the mPFC as a consequence of 6-OHDA lesions in this area 
produce an enhancement of cocaine-incduced dopamine transmission in the 
NAc, an increase in K+ stimulated dopamine release and  increased  
DOPAC concentrations after footshock stress in the NAc19,72,225. This 
reciprocity would also predict that the basal TH levels in the mPFC are 
higher in APO-UNSUS than in APO-SUS rats. Careful inspection of fig 6A 
and 6B shows that there was indeed such a trend in virtually all parts of the 
mPFC. Statistical analyses showed that it reached significance only in one 
subarea (IL1), possibly due to the relatively low number of TH-IR 
varicosities in the mPFC as compared to the NAc. As a result of this, 
possible subtle differences might have been masked by the sampling error of 
the method.  
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Reasoning along the same lines as for the NAc (that cocaine increases TH to 
a greater extent in rats with a lower basal level of TH), would predict that 
cocaine increased TH-IR in the mPFC of APO-SUS rats, but not in APO-
UNSUS rats, which is in agreement with the present data.  
Surprisingly, in APO-UNSUS rats we even found a decrease in TH-IR in a 
few regions of the mPFC (most notably the PrL1, PrL6 and IL1, see fig 6A). 
This suggests that the dopamine synthesis in the mPFC is reduced in these 
animals. In this respect it is important to realise that cocaine also reduces 
cell firing of the dopaminergic cells104, resulting from a stimulation of 
autoreceptors by higher extracellular dopamine levels26,119. Given the above-
mentioned reciprocity between the mesolimbic and mesocortical system, the 
increase in TH-IR in the NAc of APO-UNSUS rats may lead to a further 
reduction in mPFC TH-IR. Thus it could be that the balance between 
increasing and decreasing TH is shifted into the direction of a decrease in 
the case of APO-UNSUS rats. 
Another point that should be adressed is the fact that differences were 
observed in some, but not all subareas of the mPFC (see Table IIB). What 
can be extracted from these data, is that response of the IL and PrL areas to 
cocaine within the rat lines was similar in layers 1, 2 and 3 and 5, but 
different in layer 6 (see table IIB); namely an increase in TH-IR  was 
observed in the PrL6 of APO-SUS and a decrease in the PrL6 of APO-
UNSUS rats, whereas in IL6 cocaine had no effect in either type of rat. 
Thus, there is a difference in response to cocaine between the IL and PrL, 
but only in layer 6, which is partly in agreement with an earlier mentioned 
study, showing that the PrL is more important in mediating certain cocaine-
induced behaviours231,232.  
   
Substantia Nigra, pars compacta and Ventral Tegmental Area 
This study showed that in the medial part of the SNc and in the PB of the 
VTA, APO-UNSUS rats had a higher density of TH-IR cell bodies than 
APO-SUS rats. This seems to be in contrast to a previous study in which it 
was found that APO-SUS rats had higher levels of TH mRNA in the SNc 
than APO-UNSUS rats196. In addition, no differences in TH mRNA in the 
VTA between these rats were found in that study. It is highly intriguing that 
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TH mRNA levels are not directly coupled to TH protein levels. This might 
indicate that the translation from mRNA to protein levels differs between 
APO-SUS and APO-UNSUS rats. However, it should also be noted that the 
methods for quantification were completely different between our study and 
the study of Rots et al. They have used in situ hybridization combined with 
image analysis measuring the optical density of the staining, whereas we 
used immunocytochemistry combined with the quantification of the 
numerical density of cell bodies. 
The present study also demonstrated that cocaine increased the density of 
TH-IR cell bodies in the medial part of the SNc, but not in the lateral part. 
Studies have shown that the medial part of the SNc has intensive 
connections with the NAc, whereas the lateral part does not, but is 
connected with the dorsal striatum. Thus, the data of this study are in line 
with the notion that the dopaminergic cells projecting to the NAc are of 
special importance as neural substrate of cocaine191.  Cocaine also increased 
the density of TH-IR cell bodies in all subregions of the VTA of both rat 
lines, a finding that is in agreement with the notion that both the mesolimbic 
and the mesocortical systems are involved in responses to drugs of abuse 
141.  
 
General conclusion 
This study clearly showed that cocaine differentially affected both the 
dopaminergic mesolimbic and the dopaminergic mesocortical system in 
APO-SUS and APO-UNSUS rats. Whereas the cocaine-induced increase in 
TH-IR cell bodies of these systems was similar in these rats, the cocaine-
induced changes of the TH-IR varicosities in the terminal areas differed 
between APO-SUS and APO-UNSUS rats. Cocaine caused an increase in 
TH-IR in the NAc of APO-UNSUS rats, but not in the NAc of APO-SUS 
rats. Conversely, cocaine increased TH-IR in parts of the mPFC of APO-
SUS rats, but decreased TH-IR in some subareas of the mPFC of APO-
UNSUS rats. Finally, the effects of cocaine on noradrenaline are not 
conclusive in this study and remain open for investigation. 
The data from the present study underline the importance of considering the 
neuroanatomical substrate when studying the effects of cocaine on TH-IR, 
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because cocaine-induced effects on TH-IR are different between subregions 
of brain areas, in this study most prominently in the mPFC. Moreover, it 
appears to be very important to realise that cocaine-induced effects on TH-
IR can differ considerably between rat lines.   
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Abstract 
Amphetamine is often used to mimic certain aspects of schizophrenia in 
laboratory animals, such as a decreased prepulse inhibition. Apomorphine-
susceptible and apomorphine-unsusceptible rats represent a well-
characterized animal model for individual differences in the sensitivity to 
dopaminergic drugs. Moreover, apomorphine-susceptible rats show a wide 
variety of schizophrenia-like abnormalities. The differential response to 
administration of amphetamine (1-4 mg/kg, i.p.) was investigated in these 
two rat lines using the prepulse inhibition paradigm. Because amphetamine 
promotes dopamine release, the cellular mechanism underlying the line-
specific effects of amphetamine was investigated by administration of alpha-
methyl-para-tyrosine and reserpine, substances that are known to deplete the 
cytosolic dopamine pool and the vesicular dopamine pool respectively, the 
former being primarily implicated in mediating the effects of amphetamine. 
All doses of amphetamine decreased prepulse inhibition in apomorphine-
susceptible rats, whereas only the highest doses (2 and 4 mg/kg, i.p.) of 
amphetamine decreased prepulse inhibition in apomorphine-unsusceptible 
rats. Alpha-methyl-para-tyrosine, but not reserpine, blocked the 
amphetamine-induced disruption in prepulse inhibition in apomorphine-
unsusceptible rats, whereas both substances alone had no effect in 
apomorphine-susceptible rats. However, the combination of alpha-methyl-
para-tyrosine and reserpine did block the amphetamine-induced effects in the 
latter rat line.  
The present study suggests that apomorphine-susceptible rats are more 
sensitive to systemic administration of amphetamine than apomorphine-
unsusceptible rats. In addition, the data show that the cellular mechanism 
underlying the effects of amphetamine differs between apomorphine-
susceptible and apomorphine-unsusceptible rats. Whereas the effects of 
ampehatamine on prepulse inhibition in apomorphine-unsusceptible rats just 
require the alpha-methyl-para-tyrosine sensitive dopamine pool, the effects 
in apomorphine-susceptible rats require both the alpha-methyl-para-tyrosine 
sensitive and the reserpine sensitive dopamine pool. Because apomorphine-
susceptible rats share many features with schizophrenic patients, these data 
open the perspective that in these patients amphetamine may induce 
dopamine release from both types of dopamine pool. This might provide an 
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explanation for the increased dopamine release following this 
psychostimulant drug in patients versus controls.  
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Introduction 
Amphetamine is a psychostimulant drug that can induce and exacerbate the 
symptoms of schizophrenic patients 51. Moreover, schizophrenic patients are 
more sensitive to the emotional and physical effects of amphetamine than 
healthy subjects 147. Amphetamine enters the nerve terminal through the 
dopamine transporter (DAT), reverses the function of the DAT and thereby 
promotes the release of dopamine 143. Recently, it has also been shown that 
schizophrenic patients show a larger dopamine release following 
amphetamine administration than healthy subjects 2.  For these reasons, 
amphetamine  is often used in animal models to mimic certain aspects of 
schizophrenia. Most notably, amphetamine strongly decreases prepulse 
inhibition (PPI; 155, a measure of sensorimotor gating which is reduced in 
schizophrenic patients 21,97. The effects of amphetamine on PPI can be 
reversed by the dopamine D2 receptor antagonist haloperidol 91.  
As mentioned above, amphetamine promotes the release of dopamine from 
the nerve terminal. It is important to realize that the dopaminergic nerve 
terminal contains at least two different dopamine pools which can be 
selectively influenced by different drugs: the alpha-methyl-para-tyrosine 
(aMpT) sensitive pool and the reserpine sensitive pool 7,254. The aMpT 
sensitive pool contains newly synthesized dopamine and can therefore be 
depleted by the tyrosine hydroxylase (TH) inhibitor aMpT 168. The reserpine 
sensitive pool is responsible for vesicular dopamine storage and can be 
depleted by the vesicular monoamine transporter inhibitor reserpine, which 
blocks the uptake of cytosolic dopamine into vesicles 105. These two pools 
have a differential function in mediating the effects of amphetamine. Thus, it 
has been shown that administration of aMpT, but not reserpine, can inhibit 
amphetamine-induced behavioural and neurochemical effects 29,36,61,75,93,206. 
However, the two pools do not work completely independent of each other 
7,143. A constant exchange of dopamine between these pools is present and 
administration of high doses of amphetamine mediates an effect that is 
dependent on dopamine in both pools, most likely due to a redistribution of 
dopamine from the reserpine-sensitive pool to the aMpT-sensitive pool 
93,122,214,215,248. 
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Given the fact that amphetamine is promotes a higher dopamine release in 
patients with schizophrenia than in healthy subjects (see above), it becomes 
interesting to know to what extent this is due to a differential role of the two 
pools in amphetamine-induced effects in patients versus controls. Over the 
past years we have developed an animal model for individual differences in 
responses to dopaminergic drugs, namely the apomorphine-susceptible 
(APO-SUS) and apomorphine-unsusceptible (APO-UNSUS) rat lines 54. 
Apart from the differential responsiveness to apomorphine, the APO-SUS 
rats show a wide variety of schizophrenia-like disturbances, including a 
reduction in PPI 83 as well as an enhanced sensitivity to stressors and a shift 
from TH1 to TH2 cells 82. It has also been shown that APO-SUS rats are more 
responsive to local administration of amphetamine than APO-UNSUS rats 81. 
Moreover, we have recently found that APO-SUS rats release more 
dopamine within the nucleus accumbens after a mild stressor than APO-
UNSUS rats 235. Hence, this animal model could help elucidate the 
involvement of the two different dopamine pools in the effects of 
amphetamine.  
The first aim of this study was to investigate whether the acute behavioural 
response to systemic administration of  amphetamine differs between APO-
SUS and APO-UNSUS rats, using the PPI paradigm. Given the increased 
sensitivity of schizophrenic patients for amphetamine, we hypothesized that 
amphetamine will decrease PPI to a larger degree in APO-SUS rats than in 
APO-UNSUS rats. Since amphetamine, to a minor degree, also increases the 
release of noradrenaline 139 and serotonin 9, we additionally tested the 
dopamine specificity by analyzing whether the D2 receptor antagonist 
remoxipride could reverse the amphetamine-induced deficits in PPI.  
The second aim was to investigate to what extent the amphetamine-induced 
disruption of PPI was due to dopamine released from the aMpT-sensitive or 
from the reserpine-sensitive pool. For that purpose, it was analyzed whether 
the amphetamine-induced disruption of PPI could be reversed by pre-
treatment with either aMpT or reserpine, respectively. Previous studies have 
shown that, under baseline conditions, APO-SUS rats have higher levels of 
TH in the NAc than APO-UNSUS rats 234,235. Therefore, we hypothesized 
that aMpT is less potent in blocking the amphetamine-induced disruption in 
PPI in APO-SUS rats than in APO-UNSUS rats. In addition, based on the 
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existing literature  that amphetamine-induced effects are primarily dependent 
upon dopamine in the aMpT-sensitive pool, and not (or to a lesser degree) 
upon dopamine in the reserpine-sensitive pool (see above), we hypothesized 
that reserpine is unable to block the amphetamine-induced disruption in PPI 
in both rat lines. 
 
Material and methods 
Animals 
A total of 270 naïve male APO-SUS and APO-UNSUS rats of the 20th and 
21st generation of the replicated line of approximately 3 months old were 
used85. The number of animals per experimental group is displayed in table I 
and in the figures. These rats were bred and reared in the Central Animal 
Laboratory of the Radboud University Nijmegen. Rats were housed in 
groups of 2 or 3 animals per cage (Macrolon, 42 x 26 x 20 cm) in air 
humidity and temperature-controlled rooms (21 ± 20C) on a 12/12 hr 
light/dark cycle (lights on at 07.00 am).  Food and water were available ad 
libitum in the home cages. Rats were housed individually one day prior to 
testing. 
All experiments were carried out in accordance with institutional, national 
and international guidelines for animal care and the Dutch law concerning 
animal welfare. 
Drug treatment 
All drugs were administered intraperitoneally. Dose-response curves of the 
following substances were made: amphetamine (0, 1, 2 and 4 mg/kg), 
administered 15 min prior to PPI; aMpT (0, 50, 100 and 200 mg/kg), given 
60 min prior to PPI. Remoxipride (5.0 mg/kg) was given 30 min prior to PPI. 
This dose was chosen on the basis of pilot studies in our lab. Reserpine was 
only tested in a dose of 1 mg/kg, given 24 hours prior to PPI. We decided 
not to test higher doses of reserpine, because the chosen dose of reserpine 
already affected the basal startle amplitude in APO-UNSUS rats. 
On the basis of the outcome of the dose-response curves, the best dose of 
amphetamine and  aMpT were selected to test whether aMpT could block 
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the amphetamine-induced disruption of PPI. The best dose of amphetamine 
was also used in order to test whether reserpine could block the 
amphetamine-induced disruption of PPI. 
Compounds 
The following compounds and solutions were used during the experiments: 
d-amphetamine HCl (Sigma (RBI), Natick, MA, USA), dl-alpha-Methyl-
para-Tyrosine (Axel Kistner ab, Göteborg, Sweden), remoxipride (Astra, 
Sodertalje, Sweden) and reserpine (Daiichi, Tokyo, Japan), aliquots 
containing 1 mg reserpine per ml solvent. Apart from reserpine, all drugs 
were dissolved in saline. The solvent of reserpine consisted of 30 mg dl-
methionine dissolved in 10 ml aquadest containing 6.75% propylene glycol 
and 1.5 μl phosphoric acid (85%) with a pH of approximately 2.7 (all 
compounds were purchased from Sigma).   
Prepulse inhibition of the acoustic startle response 
Prepulse inhibition was measured in 4 acoustic startle chambers of San 
Diego Instruments. Each cage consists of a Plexiglas tube (8.2 cm in 
diameter, 25 cm in length) resting on a plastic frame. A piezoelectric 
accelerometer mounted under the tube detected and transduced the motion of 
the tube. Stimulus delivery was done using SR-LAB software, via a speaker 
mounted 10 cm above the cylinder. The computer software also digitized, 
rectified and recorded the response of the accelerometer, with 100 1 ms 
readings collected beginning at stimulus onset. Startle amplitude was defined 
as the average of the 100 readings. The whole system was mounted within a 
sound-attenuating chamber which was diffusely illuminated. Throughout the 
startle session a background level of 70 dB was maintained. 
The startle session started with a 5 min habituation period in the startle 
chambers, followed by 10 blocks of 5 trials to measure PPI. Each block 
consisted of one startle trial (120 dB[A], 20 ms broad band burst, the A 
refers to the A weighing scale for sound measurement)- which was delivered 
to measure basal startle responsiveness- one no-stimulus condition and three 
different prepulse-startle pairings administered pseudorandomly. In these 
pairings the prepulse was either 3, 5, or 10 dB[A] above background. These 
prepulses were always 20 ms broadband burst and given 100 ms before the 
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startle pulse (120 dB[A]). The interval between two trials was between 10 
and 20 sec. 
The startle amplitude was calculated as the mean of 10 delivered startle 
trials. The degree of prepulse inhibition (in percentage) was calculated 
according to the formula 
 
100- 
mean of all startle amplitudes on prepulse trials 
basal startle amplitude  
x 100  
 
Statistical analyses 
The basal startle amplitude and mean prepulse inhibition of the dose-
response curves of amphetamine, aMpT and reserpine were analyzed using a 
two-way analysis of variance (ANOVA) with rat line and treatment as 
independent variables, followed by an LSD (Least Significant Differences) 
post-hoc test on treatment. Subsequently, a one-way ANOVA was 
performed per rat line with treatment as independent variable, followed by 
an LSD post-hoc test on treatment. 
To evaluate whether aMpT could antagonize the effect of amphetamine, a 
one-way ANOVA was carried out with treatment (amphetamine 2 mg/kg, 
aMpT100 + amphetamine 2 mg/kg and aMpT200 + amphetamine 2 mg/kg 
groups) as independent variable, with a post-hoc LSD test on treatment.  
To evaluate whether reserpine, remoxipride or the combination of reserpine 
+ aMpT could antagonize the effects of amphetamine, an independent 
samples t-test was performed between the three former groups and the latter 
group. Data were considered statistically significant when P<0.05. All 
statistical analyses were carried out using SPSS 12.0 software (SPSS Inc., 
Chicago, Il, USA).  
 
 
Results 
Amphetamine dose-response (Fig 1) 
Analysis of the basal startle amplitude revealed no significant effect of rat 
line or treatment and no interaction between ratline and treatment (Table I).  
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APO-SUS rats had a smaller PPI when compared to APO-UNSUS rats 
(F1,55=21.1, P<0.0001, Fig 1A and B). Amphetamine decreased PPI 
(F3,55=13.7, P<0.0001, Fig 1A and B). There was no interaction between rat 
line and treatment.Because there was a rat line effect on PPI, the analysis 
was split up per rat line. A one-way ANOVA showed that there was a 
treatment effect on PPI in APO-SUS rats (F3,27=4.4, P<0.05) and the post-
hoc test indicated that all doses of amphetamine significantly reduced PPI 
(Fig 1A). There was also a treatment effect on PPI in APO-UNSUS rats 
(F3,28=12.7, P<0.0001), but only the two highest doses of amphetamine 
reduced PPI (i.e. 2.0 and 4.0 mg/kg amphetamine, Fig 1B). The decrease in 
PPI following amphetamine treatment was dose-dependent in APO-UNSUS 
rats, but not in APO-SUS rats (see Fig 1A and B). 
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Fig 1 Amphetamine dose-
response  
 All animals received a saline 
injection 60 minutes prior to 
amphetamine administration. 
All doses of amphetamine 
decreased PPI in the APO-
SUS rats (A), whereas only 
the highest doses (2 and 4 
mg/kg) decreased PPI in 
APO-UNSUS rats (B). * 
significantly different from 
the control group (P<0.05).  
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Fig 2 Antagonism of the 
amphetamine- induced 
deficits by remoxipride  
 
 
 Remoxipride completely 
blocked the amphetamine-
induced disruption in APO-
SUS rats (A), but not in APO-
UNSUS rats (B).* 
significantly different 
(P<0.05) from the 
remoxipride 0 mg/kg + 
amphetamine 0 mg/kg group; 
# significantly different 
(P<0.05) from the 
remoxipride 0 mg/kg + 
amphetamine 2 mg/kg group. 
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Antagonism of the effects of amphetamine by remoxipride (Fig 2) 
Remoxipride alone had no significant effect on basal startle amplitude 
(Table I) and PPI in both APO-SUS and APO-UNSUS rats (data not shown). 
Remoxipride decreased basal startle amplitude in both amphetamine-treated 
APO-SUS rats (t=2.3, P<0.05, Table I) and amphetamine-treated APO-
UNSUS rats (t=3.1, P<0.05, Table I). Moreover, remoxipride antagonized 
the effects of amphetamine in APO-SUS rats (t=-2.5, P<0.05, Fig 2A). 
Remoxipride did not antagonize the amphetamine-induced disruption in PPI 
in APO-UNSUS rats (Fig 2B). 
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aMpT dose-response (Fig 3) 
Overall, basal startle amplitude was significantly higher in APO-SUS than in 
APO-UNSUS rats (rat line: F1,59=14.7, P<0.0001). There were no effects of 
aMpT and no interaction between treatment and ratline in basal startle 
amplitude. 
Overall, PPI was significantly smaller in APO-SUS than in APO-UNSUS 
rats (rat line: F1,59=4.6, P<0.05. No effects of aMpT and no interaction 
between rat line and treatment were found. 
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 Fig 3 aMpT dose-response 
All animals received a saline injection 45 minutes after aMpT administration (15 min 
prior to PPI). No significant effects of any dose of aMpT was found in APO-SUS (A) 
and APO-UNSUS rats (B).  
 
 
 
 
 
 
Reserpine (Fig 4) 
There were no differences between the rat lines and no effects of reserpine 
on basal startle amplitude. However, there was a significant interaction 
between rat line and treatment (F1,25=9.9, P<0.005); reserpine did not affect 
basal startle amplitude in APO-SUS rats whereas it strongly increased this in 
APO-UNSUS rats (see Table I). 
There was no rat line effect, no treatment effect and no interaction between 
rat line and treatment in PPI (Fig 4A and B). 
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Antagonism of the effects of amphetamine by aMpT (Fig 5) 
Based on the dose-response curve of amphetamine, 2 mg/kg amphetamine 
was chosen for the antagonism study. Both 100 and 200 mg/kg aMpT were 
used to investigate the ability of aMpT to antagonize the amphetamine-
induced disruption in PPI.  
A one-way ANOVA showed that there was no treatment effect on basal 
startle amplitude in APO-SUS rats. In addition, there was no treatment effect 
on PPI, indicating that both 100 and 200 mg/kg aMpT were not able to 
antagonize the amphetamine-induced disruption in PPI in APO-SUS rats 
(Fig 5A). 
In APO-UNSUS rats, the one-way ANOVA did reveal a treatment effect on 
basal startle amplitude (F2,25=5.0, P<0.05). The post-hoc test indicated that 
200 mg/kg aMpT decreased  basal startle amplitude in amphetamine-treated 
animals (Table I).  
0 mg/kg (N=8) 1 mg/kg (N=5) Fig 4 Reserpine 
All animals received a saline 
injection 15 minutes prior to 
PPI. No effects of reserpine 
were found in both APO-SUS 
(A) and APO-UNSUS rats (B).  
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More importantly, a significant treatment effect was found on PPI (F2,25=8.2, 
P<0.005). Post-hoc analysis revealed that both 100 mg/kg and 200 mg/kg 
aMpT increased PPI of amphetamine-treated APO-UNSUS rats, indicating 
that both doses of aMpT antagonized the amphetamine-induced disruption of 
PPI in these rats (Fig 5B).   
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Fig 5 Antagonism of the 
amphetamine-induced effects 
by aMpT 
(A) In APO-SUS rats, aMpT 
did not antagonize the 
amphetamine-induced 
disruption in PPI. (B) In APO-
UNSUS rats, both doses of 
aMpT antagonized the 
amphetamine-induced 
disruption in PPI. * 
significantly different from the 
aMpT 0 mg/kg + amphetamine 
0 mg/kg group (P<0.05); # 
significantly different (P<0.05) 
from the aMpT 0 mg/kg + 
amphetamine 2 mg/kg group  
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Reserpine did not antagonize the effects of amphetamine (Fig 6) 
Because rats in the control group of this experiment (t=-24 hrs solvent 
reserpine, t=-15 min saline) were treated differently from rats in the control 
group of the amphetamine dose-response curves (t=-60 min saline, t=-15 
min saline), the effects of reserpine 0 mg/kg + amphetamine 2 mg/kg were 
first compared to the reserpine 0 mg/kg + amphetamine 0 mg/kg group. In 
APO-SUS rats, amphetamine significantly increased basal startle amplitude 
(t=-2.4, P<0.05, Table I). Amphetamine reduced PPI in these rats (t=11.3, 
P<0.0001, Fig 6A).  
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In APO-UNSUS rats, amphetamine increased basal startle amplitude (t=-3.8, 
P<0.005, Table I). Amphetamine did not significantly reduce PPI  in APO-
UNSUS rats (Fig 6B). However, there was a strong tendency towards 
reduction (t=1.8, P=0.09). 
Reserpine decreased basal startle amplitude of amphetamine-treated APO-
SUS rats (t=3.3, P<0.005, Table I). In contrast, reserpine did not antagonize 
the amphetamine-induced disruption in PPI in APO-SUS rats (Fig 6A), 
indicating that reserpine was not able to antagonize the amphetamine-
induced disruption in PPI in these rats. 
In APO-UNSUS rats, reserpine increased basal startle amplitude of 
amphetamine-treated rats (t=2.4, P<0.05, Table I). However, reserpine did 
not antagonize the amphetamine-induced deficit in PPI in APO-UNSUS rats 
(Fig 6B).  
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Fig 6 Antagonism of the 
amphetamine-induced effects 
by reserpine 
Reserpine did not antagonize 
the effects of amphetamine on 
PPI in neither APO-SUS rats 
(A) nor in APO-UNSUS rats 
(B). Amphetamine did not 
significantly reduce PPI in 
APO-UNSUS rats (B), but 
there was a trend towards 
reduction (P=0.09). * 
significantly different from the 
reserpine 0 mg/kg + 
amphetamine 0 mg/kg group 
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Antagonism of the amphetamine-induced disruption in PPI by the 
combination of reserpine and aMpT in APO-SUS rats (Fig 7) 
Since both aMpT and reserpine alone were unable to block the 
amphetamine-induced disruption in PPI in APO-SUS rats, we tested the 
combination of these substances in these rats. This experiment was not 
performed in APO-UNSUS rats, because aMpT alone was already able to 
block the amphetamine-induced disruption in PPI.  
First, the combination of reserpine 1 mg/kg + aMpT 100 mg/kg alone had no 
effect on basal startle amplitude (Table I), but it decreased PPI (t=2.6, 
p<0.05, data not shown). 
Pretreatment with reserpine and aMpT did not affect basal startle amplitude 
of amphetamine-treated rats (Table I). However, the combination of 
reserpine and aMpT antagonized the amphetamine-induced disruption in PPI 
in APO-SUS rats (t=-14.6, P<0.0001, Fig 7). 
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Fig 7 Antagonism of the amphetamine-induced effects by aMpT and reserpine in APO-
SUS rats 
The combination of reserpine and aMpT blocked the amphetamine-induced disruption in 
PPI in APO-SUS rats. *significantly different (P<0.05)from the reserpine 0 mg/kg + 
amphetamine 0 mg/kg group; # significantly different from the reserpine 0 mg/kg + 
amphetamine 2 mg/kg group (P<0.05).  
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treatment Basal startle 
amplitude +/- 
SEM APO-SUS 
Basal startle 
amplitude +/- 
SEM APO-
UNSUS 
# animals 
per group 
APO-SUS 
# animals 
per group 
APO-
UNSUS 
Saline + saline 1573 ± 268 1004 ± 111 8 8 
Saline + Amphetamine 1 mg/kg 987 ± 183 1548 ± 263 8 8 
Saline + Amphetamine 2 mg/kg 1295 ± 244 1438 ± 270 7 8 
Saline + Amphetamine 4 mg/kg 1263 ± 168 1452 ± 350 8 7 
Solvent reserpine + saline  1044 ± 204 799 ± 106 8 8 
Remoxipride 5 mg/kg + Saline 1573 ± 268  1013 ± 394  10 8 
Remoxipride 5 mg/kg + amph 2 
mg/kg 
671 ± 114 * 549 ± 337* 10 10 
aMpT 50 mg/kg + Saline 1149 ± 79 1000 ± 205 8 8 
aMpT 100 mg/kg + Saline 1184 ± 194 990 ± 228 11 8 
aMpT 200 mg/kg + Saline 1467 ± 140 530 ± 73 + 7 9 
Reserpine 1 mg/kg + Saline 717 ± 51 1625 ± 224 # 5 8 
aMpT 100 mg/kg + amph 2 mg/kg 863 ± 170 994 ± 230 7 10 
aMpT 200 mg/kg + amph 2 mg/kg 1052 ± 411 530 ± 74 8 10 
Solvent reserpine + amph 2 mg/kg 1910 ± 296 ^ 1674 ± 204 ^ 8 12 
Reserpine 1 mg/kg + amph 2 mg/kg 857 ± 119 ~ 2641 ± 340 ~ 8 9 
Reserpine 1 mg/kg + aMpT 100 
mg/kg + saline 
1111 ± 131  X 10 X 
Reserpine 1 mg/kg + aMpT 100 
mg/kg + amph 2 mg/kg 
1058 ± 552 X 8 X 
 
Table I Basal startle amplitudes 
The basal startle amplitudes ± SEM of all experimental groups are displayed in this 
table. X means that no animals were tested in this group. 
* significantly different from saline + saline group 
# significantly different from  reserpine 0 mg/kg + saline group 
+ significantly different from saline + amphetamine 2 mg/kg group 
^  significantly different from  reserpine 0 mg/kg + saline group 
~ significantly different from reserpine 0 mg/kg + amphetamine 2 mg/kg group 
** significantly different from the aMpT 0 mg/kg + amphetamine 2 mg/kg group 
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Discussion 
The present study showed that amphetamine decreased PPI in both APO-
SUS and APO-UNSUS rats, and that this effect was somewhat stronger in 
APO-SUS than in APO-UNSUS rats. We also found that the amphetamine-
induced disruption in PPI in APO-SUS rats, but not in APO-UNSUS rats, 
was completely blocked by remoxipride, indicating that the effects of 
amphetamine on PPI were dopaminergic in APO-SUS rats.  
In addition, we showed that aMpT, but not reserpine, antagonized the 
amphetamine-induced disruption in PPI in APO-UNSUS rats, but not in 
APO-SUS rats. Whereas both drugs alone were unable to antagonize the 
amphetamine-induced disruption in PPI in APO-SUS rats, the combination 
of reserpine and aMpT completely blocked this disruption.  
No major effects of most treatments were found on basal startle amplitude, 
except for reserpine, which very strongly increased basal startle amplitude in 
APO-UNSUS rats. In agreement with a previous study, the basal startle 
amplitude was in general higher in APO-SUS compared to APO-UNSUS 
rats, while PPI was smaller in APO-SUS rats than in APO-UNSUS rats 83. 
Differential response to amphetamine in APO-SUS and APO-UNSUS rats 
Given the fact that APO-SUS rats show numerous schizophrenia-like 
abnormalities 82 and patients with schizophrenia are much more sensitive to 
amphetamine 2, we hypothesized that APO-SUS rats are more responsive to 
amphetamine than APO-UNSUS rats. Indeed, we found that all doses of 
amphetamine decreased PPI in APO-SUS rats, whereas only the two highest 
doses decreased PPI in APO-UNSUS rats, suggesting that APO-SUS rats are 
indeed more sensitive to the acute behavioural effects of amphetamine than 
APO-UNSUS rats. This difference in sensitivity to amphetamine adds to the 
growing body of literature on strain and breeder differences in the disruptive 
effects of dopaminergic drugs such as apomorphine and amphetamine on 
PPI 131,219,221,249.  
We found that the amphetamine-induced disruption in PPI in APO-SUS rats 
was completely blocked by the chosen dose of the D2 receptor antagonist 
remoxipride. In contrast, this was not the case in APO-UNSUS rats. 
Unfortunately, the combination of the chosen dose of remoxipride with 
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amphetamine already severely diminished basal startle amplitude, therefore 
precluding the use of higher doses. Thus, it remains unclear whether the 
effects of amphetamine in the APO-UNSUS rats are fully dopaminergic. 
Antagonism of the amphetamine-induced effects by aMpT  
The second aim of this study was to investigate whether the cellular 
mechanism underlying the response to amphetamine differed between APO-
SUS and APO-UNSUS rats. We found that the amphetamine-induced 
disruption of PPI in APO-UNSUS rats was significantly antagonized by 
aMpT, but not by reserpine. These data are in agreement with the existing 
literature describing that the cellular mechanism of action of amphetamine is 
especially dependent on activation of the newly synthesized, aMpT-sensitive 
dopamine pool and not on the activation of the reserpine-sensitive storage 
pool 61,106,144. 
Interestingly, the effects of amphetamine on PPI in APO-SUS rats were only 
reversed by combined pre-treatment with aMpT and reserpine, whereas both 
aMpT and reserpine alone had no effect on the amphetamine-induced PPI 
disruption in these rats. This indicates that the effects of amphetamine in 
APO-SUS rats are not only dependent on dopamine from the aMpT-sensitive 
pool, but also on dopamine from the reserpine-sensitive pool. If both 
dopamine pools are involved in the amphetamine-induced dopamine release, 
it can be hypothesized that overall dopamine release is higher than if only 
one dopamine pool is activated. Because dopamine levels are inversely 
correlated with PPI 97,258, this might also explain the somewhat stronger 
amphetamine-induced reduction in PPI of APO-SUS rats than that of APO-
UNSUS rats. Given the fact that APO-SUS rats share many features with 
schizophrenic patients, it is tempting to speculate that the effects of 
amphetamine in these patients are also mediated by dopamine from both the 
aMpT-sensitive pool and the reserpine-sensitive pool, which thus might 
explain the larger increase in dopamine release in these patients 2.  
At present it is difficult to explain why amphetamine influences both pools 
in the APO-SUS and only the aMpT-sensitive pool in APO-UNSUS rats. 
Whether this means that the dopamine pools in APO-SUS and APO-UNSUS 
rats differ in size, or whether trafficking of dopamine between these pools 
differs between the rat lines awaits further investigation. 
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General conclusion 
Firstly, we found that amphetamine (2 and 4 mg/kg) decreased PPI in both 
rat lines. However, the lowest dose of amphetamine (1 mg/kg) already 
affected PPI in APO-SUS rats, but not in APO-UNSUS rats. These data 
imply that APO-SUS rats are somewhat more sensitive to the acute 
behavioural effect of amphetamine than APO-UNSUS rats. 
Secondly, we demonstrated that the amphetamine-induced disruption in PPI 
was dopaminergic, at least in APO-SUS rats, since the effects could be fully 
blocked by the D2 antagonist remoxipride. 
Thirdly, we showed that aMpT, but not reserpine, antagonized PPI-induced 
disruption by amphetamine in APO-UNSUS rats, but not in APO-SUS rats. 
Moreover, we found that the combination of reserpine and aMpT completely 
blocked the amphetamine-induced disruption in PPI in APO-SUS rats.  
Together, the data from this study suggest that the magnitude of the response 
to amphetamine is different between APO-SUS and APO-UNSUS rats. 
Moreover, the data suggest that the cellular mechanism underlying the 
effects of amphetamine differ between APO-SUS and APO-UNSUS rats. 
Given the fact that APO-SUS rats have many features in common with 
schizophrenic patients, these data open the perspective that in these patients 
amphetamine may also influence both dopamine pools, which could explain 
the higher dopamine release of these patients following administration this 
psychostimulant drug.  
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Abstract 
Dopaminergic agonists, such as apomorphine and amphetamine, have been 
shown to drastically reduce prepulse inhibition of the acoustic startle reflex. 
The effects of the indirect dopamine agonist cocaine on prepulse inhibition 
have only been described in a few reports and have yielded conflicting 
results, possibly due to individual differences within and between rat strains. 
In this study we therefore used apomorphine-susceptible and apomorphine-
unsusceptible rats, as an animal model for individual differences, to study 
the effects of cocaine (20, 30 mg/kg i.p.) on prepulse inhibition. In addition 
we tested whether the cocaine-induced deficit in prepulse inhibition could be 
reversed by the D2-antagonist remoxipride (5 mg/kg, i.p.), the alpha-1 
adrenoceptor antagonist prazosin (2.5 mg/kg, i.p.) and the 5HT2-antagonist 
ketanserin (2.0 mg/kg, i.p.). 
Cocaine strongly reduced prepulse inhibition in apomorphine-susceptible 
rats, but had no effect at all on apomorphine-unsusceptible rats. Remoxipride 
had no effect on prepulse inhibition, but prazosin and ketanserin increased 
prepulse inhibition. Both remoxipride and prazosin reversed the cocaine-
induced deficit in prepulse inhibition, whereas ketanserin did not. 
We conclude that apomorphine-susceptible rats are extremely sensitive to 
the effects of cocaine on prepulse inhibition, while apomorphine-
unsusceptible rats are not. The effects of cocaine on prepulse inhibition in 
apomorphine-susceptible rats were mediated by D2-receptors, but not by 
5HT2-receptors or alpha-1 adrenoceptors.  
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Introduction 
Prepulse inhibition (PPI) of the acoustic startle response is the reduction of 
an organism’s startle response when a startling stimulus is preceeded by a 
weaker prestimulus, or prepulse,  presented 30-500 ms before the startling 
stimulus 97. This phenomenon is present in many species, including humans 
and laboratory animals, and is often used to investigate the underlying 
mechanisms contributing to neuropsychiatric disorders such schizophrenia21, 
obsessive-compulsive disorder217, Tourette’s syndrome41 and Huntington’s 
disease220. These disorders are all characterized by a deficit in PPI, which 
reflects abnormalities in sensorimotor gating.  
One of the most important neurotransmitters involved in the modulation of  
PPI is dopamine155. In particular, administration of direct (such as 
apomorphine) or indirect (such as amphetamine) dopamine agonists has been 
reported to strongly reduce PPI68,84,258. Co-administration of these substances 
with dopamine antagonists fully restores PPI, providing solid evidence that 
dopamine transmission is of critical importance in the regulation of PPI91,218 
(Van der Elst et al., submitted).  
Cocaine is a psychostimulant and a potent blocker of the dopamine 
transporter (DAT)190. It causes an increase in extracellular levels of 
dopamine in a variety of brain structures including the nucleus accumbens 
(NAc) and is therefore, like amphetamine, an indirect dopamine agonist25,167. 
However, the effects of cocaine on PPI in rats have been investigated only in 
a few studies and have yielded conflicting results30,158,243,258. This might be 
due to differences between and within rat strains. In addition, although it is 
known that cocaine increases dopamine transmission, there are no studies 
demonstrating the efficacy of dopamine or other neurotransmitter 
antagonists in blocking the cocaine-induced deficit in PPI. 
In the current study we used two pharmacogenetically selected rat lines (i.e. 
the apomorphine-susceptible, APO-SUS, and apomorpine-unsusceptible rats, 
APO-UNSUS), that show differences in the dopaminergic system, to 
evaluate the effects of cocaine on PPI54,196,234,235. For instance, APO-SUS rats 
are more susceptible to the behavioural effects of the D1/D2 agonist 
apomorphine and show a stronger reduction in PPI after administration of 
amphetamine than APO-UNSUS rats82 (Van der Elst et al., in prep). 
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Considering these data, we hypothesize that APO-SUS rats are also more 
susceptible to the effects of cocaine on PPI than APO-UNSUS rats. Because 
cocaine is not only a powerful blocker of the DAT, but can also block the 
noradrenaline transporter (NET) and the serotonin transporter (SERT), we 
also investigated the involvement of the dopamine D2 receptor,  the 5-HT2 
receptor and the α1 –adrenoceptor in the effects of cocaine on PPI195,233.  
Materials and Methods 
Animals 
A total of 104 naïve male APO-SUS and APO-UNSUS rats of the 20th and 
21st generation of the replicate line of approximately 3 months old were 
used85. The number of animals per experimental group is displayed in table I 
and in the figures. These rats were bred and reared in the Central Animal 
Laboratory of the Radboud University Nijmegen. Rats were originally 
housed in groups of 2 or 3 animals per cage (Macrolon, 42 x 26 x 20 cm) in 
air humidity and temperature-controlled rooms (21 ± 20C) on a 12/12 hr 
light/dark cycle (lights on at 07.00 am).  Food and water were available ad 
libitum in the home cages. Rats were housed individually one day prior to 
testing. 
All experiments were carried out in accordance with institutional, national 
and international guidelines for animal care and the Dutch law concerning 
animal welfare. 
 
Drug treatment 
All drugs were administered intraperitoneally and dissolved in saline (0.9% 
NaCl). A dose response curve was made of cocaine HCl (0, 20 and 30 
mg/kg, Brocacef, Amsterdam, The Netherlands). All animals received  a 
saline injection 30 min prior to PPI, and cocaine 15 min prior to PPI. In 
order to evaluate whether remoxipride (5 mg/kg, Astra, Sodertalje, Sweden), 
prazosin (2.5 mg/kg, Sigma-Aldrich, Steinheim, Germany) or ketanserine 
(2.0 mg/kg, Sigma-Aldrich, Steinheim, Germany) were able to antagonize 
the effects of cocaine on PPI, these substances were administered 30 min 
prior to PPI, in combination with either saline or cocaine (30 mg/kg) 15 min 
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prior to PPI. The antagonism studies were performed only in APO-SUS rats, 
because APO-UNSUS rats showed no decrease in PPI after cocaine (see 
Results). All doses were based on pilot studies in our lab. 
Prepulse inhibition of the acoustic startle response 
Prepulse inhibition was measured in 4 acoustic startle chambers of San 
Diego Instruments. Each cage consists of a Plexiglas tube (8.2 cm in 
diameter, 25 cm in length) resting on a plastic frame. A piezoelectric 
accelerometer mounted under the tube detected and transduced the motion of 
the tube. Stimulus delivery was done using SR-LAB software, via a speaker 
mounted 10 cm above the cylinder. The computer software also digitized, 
rectified and recorded the response of the accelerometer, with 100 1 ms 
readings collected beginning at stimulus onset. Startle amplitude was defined 
as the average of the 100 readings. The whole system was mounted within a 
sound-attenuating chamber which was diffusely illuminated. Throughout the 
startle session a background level of 70 dB was maintained. 
The startle session started with a 5 min habituation period in the startle 
chambers, followed by 10 blocks of 5 trials to measure PPI. Each block 
consisted of one startle trial (120 dB[A], 20 ms broad band burst, the A 
refers to the A weighing scale for sound measurement)- which was delivered 
to measure basal startle responsiveness- one no-stimulus condition and three 
different prepulse-startle pairings administered pseudorandomly. In these 
pairings the prepulse was either 3, 5, or 10 dB[A] above background. These 
prepulses were always 20 ms broadband burst and given 100 ms before the 
startle pulse (120 dB[A]). The interval between two trials was between 10 
and 20 sec. 
The startle amplitude was calculated as the mean of 10 delivered startle 
trials. The degree of prepulse inhibition (in percentage) was calculated 
according to the formula 
 
 
100- 
mean of all startle amplitudes on prepulse trials 
basal startle amplitude  
x 100  
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Statistical analysis 
First, the effects of cocaine on PPI were analyzed using a two-way analysis 
of variance (ANOVA) for repeated measures with rat line and treatment as 
independent variables and prepulse intensity (3,5 and 10 dB above 
background) as repeated measure. Because a siginificant treatment effect, rat 
line effect and an interaction between treatment and ratline was found, 
analysis was subsequently split up per rat line (one-way ANOVA for 
repeated measures with treatment as independent variable and prepulse 
intensity as repeated measure, LSD post-hoc test on treatment). The basal 
startle amplitude was analyzed using a two-way ANOVA with rat line and 
treatment as independent variables. 
Second, the effects of remoxipride, prazosin and ketanserin alone were 
analyzed using a one-way ANOVA with repeated measures with treatment 
as independent variable and prepulse intensity as repeated measure. Changes 
in basal startle amplitude were analyzed using an independent-samples t-test 
between the control goup and the drug-treated group.   
Finally, to evaluate whether there was a statistical difference between the 
saline+cocaine treated group and the remoxipride/prazosin/ketanserin 
+cocaine treated groups in APO-SUS rats, we used an ANOVA for repeated 
measures (treatment as independent variable, prepulse intensity as repeated 
measure). If a statistical difference was found between the saline+cocaine 
and remoxipride/prazosin/ketanserin + cocaine groups, a two-way ANOVA 
for repeated measures was carried out with pretreatment (saline-saline and 
cocaine-saline) and treatment (remoxipride/ketanserin/prazosin-saline and 
remoxipride/ketanserin/prazosin-cocaine) as independent variables and 
prepulse intensity as within-subjects factor in order to evaluate whether the 
effects of cocaine were pharmacologically antagonized by the chosen 
antagonists. Data were considered significant when P<0.05. All analyses 
were done using SPSS 12.0.1 software (SPSS Inc., Chicago, Il, USA).  
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Results 
Cocaine dose-response (Fig 1) 
Analysis of the basal startle amplitude revealed a rat line effect (F1,43=8.2, 
P<0.01, Table I). There also was a treatment effect (F2,43=12.5, P<0.0001). 
The post-hoc test showed that 20 mg/kg cocaine significantly differed from 
control: it increased basal startle amplitude (Table I). No interaction between 
rat line and treatment were found in basal startle amplitude. 
To analyze the effects of cocaine on PPI, we included prepulse intensity as a 
repeated measure in the analysis. There was an effect of prepulse intensity 
(F2,86=73, P<0.0001), but no interactions were found between prepulse 
intensity and rat line, prepulse intensity and treatment and prepulse intensity, 
treatment and ratline. However, a significant interaction was found between 
rat line and treatment (F2,43=7,2, P<0.005), indicating that APO-SUS and 
APO-UNSUS rats reacted differently to cocaine treatment.  
Subsequently, analysis was split up per rat line. A one-way ANOVA for 
repeated measures revealed a significant effect of treatment (F2,21=11.6, 
P<0.0001) and prepulse intensity (F2,44=46, P<0.0001) in APO-SUS rats. No 
interaction between treatment and prepulse intensity was found. The post-
hoc test showed that both 20 and 30 mg/kg cocaine significantly reduced PPI 
in APO-SUS rats (Fig 1A). 
For the APO-UNSUS rats,  an effect of prepulse intensity was found 
(F2,42=31, P<0.0001), but no effects of cocaine were found on PPI and no 
interaction between prepulse intensity and treatment was found (Fig 1B).  
Because no interactions were found between treatment and prepulse 
intensity, data are depicted as mean PPI (average of PPI at 3, 5 and 10 dB[A] 
above background). 
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Fig 1. Mean prepulse inhibition ± SEM after administration of 0, 20 and 30 mg/kg 
cocaine in APO-SUS (A) and APO-UNSUS (B) rats. Cocaine dose-dependently 
decreased PPI in APO-SUS rats (A), but had no effect on APO-UNSUS rats (B). * 
indicates significant differences from the control group (saline + saline). 
 
Antagonism of cocaine-induced deficit in PPI by remoxipride 
First, remoxipride alone had no effects on basal startle amplitude (Table I).  
Remoxipride did not affect the basal startle amplitude of rats treated with 
cocaine (Table I).  
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Treatment with remoxipride alone had no effect on PPI and no interaction 
was found between prepulse intensity and treatment (Fig 2). An effect of 
prepulse intensity was found (F2,32=31,4, P<0.0001). 
A one-way ANOVA for repeated measures, comparing the PPI of rats 
treated with cocaine and rats treated with the combination of remoxipride 
and cocaine revealed  a significant effect of prepulse intensity (F2,32=16,5, 
P<0.001), but no interaction between prepulse intensity and treatment. Most 
importantly, a significant difference was found between PPI of the 
saline+cocaine and the remoxipride+cocaine rats (treatment effect: 
F1,16=28,5, P<0.001; Fig 3). Subsequently, a significant interaction was 
shown between pretreatment and treatment (F1,32=21,6, P<0.0001), 
indicating that remoxipride pharmacologically antagonized the effects of 
cocaine on PPI. (Because no interactions were found between treatment and 
prepulse intensity, data are shown as mean PPI (Fig 3).  
 
Antagonism of cocaine-induced deficit in PPI by prazosin 
Prazosin alone had no effects on basal startle amplitude (Table I), but it 
decreased the basal startle amplitude of rats treated with cocaine (t=3.0, 
P<0.05, Table I).  
Treatment with prazosin alone increased PPI (F1,14=10,6, P<0.01). In 
addition an effect of prepulse was found (F2,28=49, P<0.0001). Moreover, an 
interaction was found between prepulse intensity and treatment (F2,28=3,8, 
P<0.05). Prazosin increased PPI at prepulse intensities 3 dB[A] 
(t=2,7,P<0.05) and 5 dB[A] (t=3,7, P<0.01), but not at 10 dB[A] above 
background (Fig 2). 
Comparing the PPI of rats treated with cocaine with the PPI of rats treated 
with the combination of prazosin and cocaine revealed an effect of prepulse 
intensity (F2,30=10,0, P<0.001), but no interaction between prepulse intensity 
and treatment. Moreover, a difference was demonstrated between the PPI of 
the saline+cocaine and the prazosin+cocaine treated rats (treatment effect: 
F1,15=7,7, P<0.05). However, there was no significant interaction between 
pretreatment and treatment (F1,29=1.1, P=0.3), indicating that prazosin did 
not pharmacologically antagonize the effects of cocaine on PPI. Because no 
interactions were found between treatment and prepulse intensity, data are 
represented as mean PPI (Fig 3). 
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Antagonism of cocaine-induced deficit in PPI by ketanserin 
Ketanserin alone had no effects on basal startle amplitude, but it decreased 
the basal startle amplitude of rats treated with cocaine (t=2.5, P<0.05, Table 
I).  
Ketanserin alone increased the PPI of APO-SUS rats (treatment effect: 
F1,14=7,9, P<0.05). In addition an effect of prepulse intensity was found 
(F2,28=32, P<0.0001). Moreover, there was an interaction between prepulse 
intensity and treatment (F2,28=7,2, P<0.05): ketanserin increased PPI at 
prepulse intensities 3 dB[A] (t=3,2, P<0.01) and 5 dB[A] (t=3.0, P<0.05), 
but not at 10 dB[A] above background (Fig 2).  
In contrast, ketanserin had no effect on PPI of cocaine-treated rats, indicating 
that ketanserin was not able to antagonize the effects of cocaine (Fig 3). An 
effect of prepulse intensity was found (F2,32=24, P<0.0001), but no 
interaction was found between prepulse intensity and treatment and thus the 
data are displayed as mean PPI (Fig 3). 
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Fig 2. Effects of adminstration of remoxipride, prazosin and ketanserin on PPI in 
APO-SUS rats. Data are expressed as mean prepulse inhibition ± SEM. 
Remoxipride had no effect on PPI, but both prazosin and ketanserin increased PPI 
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Fig 3. Antagonism of the cocaine-induced deficit in PPI by remoxipride, prazosin 
and ketanserin in APO-SUS rats. Data are expressed as mean prepulse inhibition ± 
SEM. Cocaine decreased PPI (*, P<0.001). PPI was higher in the remoxipride + 
cocaine and the prazosin + cocaine groups versus the saline + cocaine group (#, 
P<0.05), indicating that remoxpride and prazosin reversed the cocaine-induced 
deficit in PPI. Ketanserin did not antagonize the cocaine-induced PPI disruption. 
 
 
treatment Basal startle 
amplitude +/- 
SEM APO-SUS 
Basal startle 
amplitude +/- 
SEM APO-
UNSUS 
# animals 
per group 
APO-SUS 
# animals 
per group 
APO-
UNSUS 
Saline + saline  1044 ± 204 799 ± 106 8 8 
Saline + Cocaine 20 mg/kg 1767 ± 207 * 1256 ± 172 * 8 8 
Saline + Cocaine 30 mg/kg 938 ± 153 590 ± 70  8 9 
Remoxipride 5 mg/kg + Saline 1573 ± 268 X 10 X 
Prazosin 2.5 mg/kg + Saline 730 ± 124 X 8 X 
Ketanserin 2.0 mg/kg + Saline 899 ± 109 X 8 X 
Remoxipride 5 mg/kg + Cocaine 30 
mg/kg 
686 ± 82 X 10 X 
Prazosin 2.5 mg/kg + Cocaine 30 
mg/kg 
392 ± 98 # X 9 X 
Ketanserin 2.0 mg/kg + Cocaine 30 
mg/kg 
479 ± 103 # X 10 X 
 
Table I Basal startle amplitudes ± SEM. Cocaine 20 mg/kg increased basal startle 
amplitude in APO-SUS and APO-UNSUS rats (*, P<0.05). The basal startle 
amplitude was lower in the prazosin 2.5 mg/kg  + cocaine 30 mg/kg and the 
ketanserin 2.0 mg/kg + cocaine 30 mg/kg group compared to the saline + cocaine 
30 mg/kg group (#, P<0.05). X means that no animals were tested in this group. 
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Discussion 
This study showed that the effects of cocaine on PPI were markedly different 
between APO-SUS and APO-UNSUS rats. Whereas cocaine strongly 
reduced PPI in APO-SUS rats, it had no effect at all on APO-UNSUS rats, 
confirming our hypothesis that APO-SUS rats are far more sensitive to the 
acute effects of cocaine on PPI than APO-UNSUS rats. 
Furthermore, the present study demonstrated that the effects of cocaine on 
PPI in APO-SUS rats can be blocked by the D2 receptor antagonist 
remoxipride (5.0 mg/kg i.p.), but not by the 5-HT2 antagonist ketanserin (2.0 
mg/kg i.p.). The α1 –adrenoceptor antagonist prazosin (2.5 mg/kg i.p.) 
antagonized the cocaine-induced disruption in PPI.  However, because 
prazosin alone also increased PPI, the role of the α1 –adrenoceptor in 
mediating the effects of cocaine on PPI is less clear. 
Very few studies have examined the effects of cocaine on PPI. Two studies 
have found that relatively high doses of cocaine (≥ 20 mg/kg) disrupted PPI 
in male and female Sprague Dawley rats30,158, while two other studies have 
found no effect of similar doses of cocaine on PPI in male Wistar and 
Sprague Dawley rats243,258. In addition, we performed some pilot studies in 
male Wistar rats and these studies also showed no effect of cocaine (10 and 
20 mg/kg) on PPI in these rats (unpublished data). Rat strain differences and 
even breeder differences in the sensitivity to the PPI-disrupting effects of 
dopaminergic drugs such as apomorphine and amphetamine have previously 
been reported131,219,221,249. This study adds to the existing literature, clearly 
showing that even within a rat strain, considerable differences are present in 
the sensitivity to the PPI disrupting effects of the indirect dopamine agonist 
cocaine. We conclude that APO-SUS rats are particularly sensitive to the 
effects of cocaine on PPI. 
Some effects of cocaine were also found on basal startle amplitude. Both in 
APO-SUS and in APO-UNSUS rats, 20 mg/kg cocaine significantly 
increased basal startle responsiveness, whereas 30 mg/kg cocaine had no 
such effect. At this point, this phenomenon cannot be easily explained. 
Increases in acoustic startle responsiveness can occur due to an increase in 
(drug-induced) anxiety, but it can also represent an overall increased 
neuronal excitability, or an overall reduction of synaptic inhibition within the 
primary reflex pathways133. However, since we were primarily interested in 
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the neuronal mechanisms underlying the effects of cocaine on PPI, we used 
the 30 mg/kg dose for our antagonism studies. Since this dose did not affect 
basal startle amplitude, our studies do not allow to make any statement with 
respect to the role of the 5-HT2, D2 or α1 receptor in this parameter. 
The fact that cocaine is not very effective in decreasing PPI is interesting in 
view of the fact that cocaine enhances dopamine neurotransmission in the 
NAc and that such an enhancement is usually associated with a decrease in 
PPI. For instance, amphetamine is very efficient in increasing dopamine 
transmission, primarily by means of reverse transport of dopamine through 
the DAT, and is consistently found to disrupt PPI, although the doses needed 
to disrupt PPI are relatively high compared to doses needed to induce 
locomotor behaviour 100,112,143,258. It has been shown that equimolar doses of 
cocaine are not as effective in increasing dopamine transmission in the NAc 
as amphetamine and accordingly, that cocaine is less effective in disrupting 
PPI than amphetamine115,258. When higher doses of cocaine are administered, 
PPI can be disrupted30,158. However, even following administration of high 
doses of cocaine, some studies still do not find any effect of cocaine on PPI 
243,258. This is also the case in this study: even at 30 mg/kg cocaine, PPI was 
still not affected in APO-UNSUS rats. A previous study has shown that 
while APO-SUS rats display a reduction in PPI to lower doses of 
amphetamine than APO-UNSUS rats, the latter rat line does show a decrease 
in PPI after higher doses of amphetamine (Van der Elst et al., in prep). The 
pronounced difference in the behavioural effects of amphetamine and 
cocaine suggests that that the different mechanisms of action between 
amphetamine and cocaine, i.e. dopamine release stimulation and dopamine 
reuptake blockade respectively,  may have functional importance. Indeed, 
whereas repeated exposure to amphetamine often leads to schizophrenic-like 
paranoid psychosis, cocaine does usually not cause such severe 
symptoms6,250. Although it is at present difficult to explain these differences, 
it is important to realize that amphetamine predominantly leads to reverse 
transport of monoamines, whereas cocaine primarily blocks these 
transporters143,190. This might lead to differences in the phasic release of 
these neurotransmitters. In addition, whereas cocaine seems to influence all 
transporters to a more or less similar degree, amphetamine is much more 
potent with respect to the dopamine and noradrenaline transporter in 
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comparison to the serotonin transporter195. However, whether either or both 
of these mechanisms can explain the reduced sensitivity of cocaine to disrupt 
PPI remains to be investigated. 
To evaluate whether the effects of cocaine on PPI were in fact dopaminergic, 
we tested whether the D2 receptor antagonist remoxipride was able to 
antagonize the effects of cocaine on PPI. Previously we have found that the 
disruptive effect of amphetamine on PPI in APO-SUS rats could be reversed 
by administration of remoxipride (Van der Elst et al., submitted). Indeed, we 
found that the cocaine-induced disruption in PPI was completely blocked by 
remoxipride, which alone, in line with other studies, had no effect on 
PPI69,121. These data indicate that the cocaine-induced effects are 
dopaminergic.  
We also tested whether the cocaine-induced effects on PPI had a 
noradrenergic component. Although we found that prazosin antagonized the 
cocaine-induced disruption in PPI, we also found that administration of the 
α1 –adrenoceptor antagonist prazosin alone increased PPI. Most studies (but 
not all, see68), even using higher doses of prazosin (>3 mg/kg) have not 
found such an effect of prazosin8,37,69. However, it can be observed that 
prazosin increases PPI to a larger degree in cocaine-treated animals than in 
saline-treated animals.  This could indicate that the effects of cocaine are 
partly mediated via α1 – adrenoceptors, but statistical analysis did not reveal 
an interaction between pretreatment and treatment, indicating that prazosin 
did not pharmacologically antagonize the effects of cocaine on PPI. Of 
course, only one dose of prazosin was used and it could thus be possible that 
using other doses provide more conclusive data. The dose for the current 
experiment was chosen because it has been found to reverse the cirazolin 
(1.0 mg/kg)-induced deficit in PPI of APO-SUS rats (Sontag et al., 
unpublished). Other studies, using male Sprague-Dawley rats, have found 
that 1.0 mg/kg prazosin could reverse the effects of 0.6 mg/kg cirazolin on 
PPI37. Because the effects of drugs are highly dependent upon strain-
differences, as underlined in the current study, we chose to use a dose of 
prazosin that was effective in APO-SUS rats, rather than using other doses 
described in literature. However, perhaps lower doses of prazosin are more 
effective in reversing the cocaine-induced PPI deficit without having an 
effect itself. 
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In addition, the 5-HT2 antagonist ketanserin was used to evaluate whether 
the 5-HT2 receptor was involved in the PPI disrupting effects of cocaine. 
Ketanserin alone increased PPI, an effect not described in literature208,242. 
However, PPI after administration of the combination of ketanserin and 
cocaine was not different from PPI after administration of cocaine alone. 
These data indicate that the chosen dose of ketanserin, which is known to 
reverse the effects of the 5-HT2 agonist DOI on PPI in male Sprague-Dawley 
rats208, was not able to antagonize the cocaine-induced decrease in PPI. 
Although perhaps other doses of ketanserin could be effective, the current 
data suggest that the 5-HT2 receptor does not seem to play a prominent role  
in mediating the effects of cocaine on PPI. 
Finally, it can be observed in Table I that both prazosin and ketanserin 
significantly reduced the startle amplitude of cocaine-treated rats, while all 
drugs by themselves had no effect on basal startle amplitude. It is not very 
likely that the decrease in basal startle amplitude influenced PPI. While 
prazosin did increase the PPI of cocaine-treated rats, ketanserin did not. 
However, both substances did have the same effect on basal startle 
amplitude of cocaine-treated rats. Thus, apparently while basal startle 
amplitude was reduced, PPI can be either enhanced or unaffected.  
In conclusion, cocaine strongly decreased PPI in APO-SUS rats, while it had 
no effect on PPI in APO-UNSUS rats. The PPI-disrupting effects of cocaine 
in APO-SUS rats are mediated by the dopamine D2 receptor, but not by the 
5-HT2 receptor and the α1 –adrenoceptor. 
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Summary of the results 
The central aim of this thesis was to investigate which neurobiological 
features contribute to the differential response of APO-SUS and APO-
UNSUS rats to drugs of abuse. 
Toward this end, both immunocytochemical and pharmacobehavioural 
studies were carried out. 
In Chapter 2, we investigated the extent of the tyrosine hydroxylase (TH) 
immunoreactive (IR) fibre network (by line-intersection counting) and the 
numerical density of TH-IR varicosities in the nucleus accumbens (NAc) of 
naive APO-SUS and APO-UNSUS rats. In this study, we showed that APO-
SUS rats had a more extensive TH-IR fibre network and a higher density of 
TH-IR varicosities in both the NAc shell and core subareas.  
In Chapter 3, we extended our study in Chapter 2 by investigating the 
response of the TH-IR fibre network and the density of TH-IR varicosities in 
the NAc to the mild environmental stressor novelty. In addition, we used 
microdialysis to investigate the amount of dopamine release in the NAc after 
novelty. First, we showed that, in line with the data from chapter 2, APO-
SUS rats had a more extensive fibre network and a higher density of 
varicosities in the NAc shell and core than APO-UNSUS rats. We did not 
find basal differences in the extracellular amount of dopamine between the 
rat lines. We demonstrated that novelty increased the extent of the TH-IR 
fibre network in APO-SUS rats, but not in APO-UNSUS rats. In line with 
this, we also showed that the amount of dopamine release in the NAc was 
higher in APO-SUS than in APO-UNSUS rats. 
In Chapter 4, we investigated the response of TH-IR varicosities in 5 
different subareas of the NAc shell and in the NAc core to cocaine 
administration (twice with a 72 h interval, 10 mg/kg, i.p.). We also 
investigated this response in the separate layers of the infralimbic (IL) and 
prelimbic (PrL) areas of the medial prefrontal cortex (mPFC). In addition, 
we investigated the noradrenergic system in the mPFC using antibodies 
against dopamine-beta-hydroxylase (DBH). Finally, we investigated the TH-
IR cell bodies in 4 subareas of the ventral tegmental area (VTA) and in the 
medial and lateral parts of the substantia nigra pars compacta (SNc). In all 
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these studies, quantification of the numerical density of varicosities or cell 
bodies was carried out using Stereo Investigator software.  
First, we validated our data from Chapters 2 and 3 showing that the baseline 
numerical density of TH-IR varicosities was higher in all areas of the NAc of 
APO-SUS rats than in those of APO-UNSUS rats. For the mPFC, basal 
differences between APO-SUS and APO-UNSUS rats only reached 
significance in IL layer 1 where APO-UNSUS rats had a higher density of 
TH-IR varicosities than APO-SUS rats. No differences between the rat lines 
were found in the density of DBH-IR varicosities. APO-UNSUS rats had a 
higher density of TH-IR cell bodies in the parabrachial area of the VTA and 
in the medial part of the SNc than APO-SUS rats. 
Cocaine treatment increased the density of TH-IR cell bodies in parts of the 
VTA and SNc in both APO-SUS and APO-UNSUS rats. However, the 
reaction in the dopaminergic terminal areas was different between these rats. 
Whereas cocaine increased the density of TH-IR varicosities in almost all 
subareas of the NAc of APO-UNSUS rats, it had no effect on this parameter 
in APO-SUS rats. In parts of the mPFC, cocaine increased the amount of 
TH-IR varicosities in APO-SUS rats, but decreased this in APO-UNSUS 
rats. Almost no effects were found on DBH-IR varicosities. 
This study clearly showed that cocaine induced line-specific effects on TH-
IR varicosities in the mPFC and NAc, whereas it induced a similar effect on 
TH-IR cell bodies in the VTA and SNc. 
In Chapter 5 we investigated the cellular mechanism underlying the effects 
of amphetamine on prepulse inhibition (PPI) in APO-SUS and APO-UNSUS 
rats. It is known that within the presynaptic dopaminergic nerve terminals at 
least two distinct dopamine pools are present, namely the alpha-methyl-
paratyrosine (aMpT)-sensitive dopamine pool and the reserpine-sensitive 
dopamine pool. aMpT is a TH-inhibitor, and thus inhibits dopamine 
synthesis, thereby depleting the newly synthesized dopamine pool. 
Reserpine is an inhibitor of the vesicular monoamine transporter (VMAT), 
which is responsible for the sequestering of cytosolic dopamine into vesicles, 
and thus administration of reserpine depletes the vesicular dopamine pool. 
These dopamine pools do not function independently of each other, since a 
constant exchange between these pools is present. However, studies have 
shown that low dose amphetamine administration induces a dopamine 
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release that is primarily dependent upon dopamine from the aMpT-sensitive 
pool, and not upon dopamine from the reserpine-sensitive pool. We 
investigated this in APO-SUS and APO-UNSUS rats, using the PPI 
paradigm, because it is known that dopamine concentrations in the NAc and 
PPI are inversely related to each other97,258. 
First, we demonstrated that APO-SUS rats are somewhat more sensitive than 
APO-UNSUS rats to acute administration of amphetamine, since all doses of 
amphetamine reduced PPI in APO-SUS rats, but only the highest doses of 
amphetamine reduced PPI in APO-UNSUS rats. 
Second, we showed that the effects of amphetamine on PPI are 
dopaminergic, at least in APO-SUS rats. Third, we showed that the 
amphetamine-induced disruption of PPI in APO-UNSUS rats, but not in 
APO-SUS rats could be reversed by aMpT. Fourth, we demonstrated that 
reserpine could not reverse the ampetamine-induced disruption in both rat 
lines. Finally, we demonstrated that the combination of aMpT and reserpine 
was able to reverse the amphetamine-induced disruption of PPI in APO-SUS 
rats. 
These data demonstrate that APO-SUS rats are somewhat more sensitive to 
amphetamine than APO-UNSUS rats and that the cellular mechanism 
underlying the effects of amphetamine on PPI are different between the rat 
lines. 
In Chapter 6, we investigated the acute response of APO-SUS and APO-
UNSUS rats to cocaine administration, again using PPI. We showed that 
APO-SUS rats are far more sensitive to cocaine than APO-UNSUS rats, 
since all doses of cocaine decreased PPI in APO-SUS rats, but had no effect 
at all on PPI in APO-UNSUS rats. In addition, we showed that the cocaine-
induced disruption of PPI in APO-SUS rats could be reversed by the D2-
receptor antagonist remoxipride and by the alpha1-adrenoceptor antagonist 
prazosin, but not by the 5HT2-receptor antagonist ketanserin. 
 
Relationship between TH and dopamine 
In Chapters 2,3 and 4 we used immunocytochemistry for the enzyme 
tyrosine hydroxylase (TH) in order to investigate the dopaminergic system in 
the brain of naive, novelty and cocaine-challenged APO-SUS and APO-
UNSUS rats. TH is the rate-limiting enzyme in dopamine biosynthesis and is 
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responsible for the conversion of tyrosine into DOPA. The fact that it is the 
rate-limiting enzyme means that it is a direct measure of dopamine synthesis. 
However, to what extent changes in TH reflect changes in dopamine 
transmission, cannot be solved at this point. In Chapter 3, we hypothesized 
that increase in dopamine release would deplete the presynaptic nerve 
terminal of dopamine and subsequently enhances dopamine synthesis, and 
thus TH has to be increased, a hypothesis that fits in with our data from the 
microdialysis study.  
As mentioned in Chapter 1, APO-SUS rats share similar features with HRs 
and APO-UNSUS rats share features with LRs. It is known that HRs show a 
larger amount of extracellular dopamine in the NAc after cocaine treatment 
than LRs113, and thus it can be hypothesized that cocaine would also increase 
the extracellular amounts of dopamine more in APO-SUS rats than in APO-
UNSUS rats. The data in Chapter 6 are consistent with this hypothesis, 
namely a stronger reduction of PPI (which is inversely coupled to the 
amount of dopamine in the NAc) in APO-SUS rats than in APO-UNSUS 
rats. Of course, the amount of extracellular dopamine following cocaine 
treatment in APO-SUS and APO-UNSUS rats should be measured in the 
future. 
In Chapter 4, we found an increase of TH-IR varicosities in the NAc after 
cocaine treatment in APO-UNSUS rats, but not in APO-SUS rats. 
Surprisingly, TH-IR was not altered in APO-SUS rats following cocaine 
treatment. We hypothesized that this is due to the fact that basal TH levels 
are higher in APO-SUS rats than in APO-UNSUS rats and that the 
intracellular concentration of dopamine is less dependent on dopamine 
reuptake. Cocaine prevents the reuptake of dopamine, by blocking the 
dopamine transporter (DAT), leading to a decrease in intracellular levels of 
dopamine. If APO-SUS rats are indeed less dependent on dopamine reuptake 
than APO-UNSUS rats, then this leads to the conclusion that TH does not 
have to be increased in APO-SUS rats. 
Thus, changes in the extracellular concentrations of dopamine are not 
directly coupled to changes in TH, but perhaps the amount of dopamine 
release is coupled to changes in TH. In this context it is interesting to realize 
that amphetamine increases dopamine release and therefore it is likely that 
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amphetamine would produce a different pattern of TH expression in APO-
SUS and APO-UNSUS rats than cocaine does. 
Another point that should be discussed in this respect is the time point at 
which TH was measured, namely 48 hours after novelty or cocaine. Changes 
in TH can occur quickly after cocaine exposure and thus it cannot be ruled 
out that the changes measured in these studies are due to secondary effects, 
such as compensatory mechanisms. It is known that cocaine has several 
effects secondary to DAT blockade, for instance TH end product 
inhibition95, TH dephosphorylation118, decrease in cell firing etc4,26,28,79. 
Thus, it would be interesting to make a time-curve of TH changes after (a 
single) administration of cocaine. For the study in Chapter 4, we chose to 
administer cocaine twice with a 72-hour interval, because this treatment 
regimen yielded differences in motor activity between APO-SUS and APO-
UNSUS rats, namely a sensitization in APO-SUS, but not in APO-UNSUS 
rats (Van der Kam et al., unpublished). 
In conclusion, the data from these studies show that APO-SUS have a more 
extensive dopaminergic innervation of the NAc than APO-UNSUS rats, 
which becomes even more intense after exposure to novelty. Cocaine has an 
opposite effect, as it increases the TH innervation in the NAc of APO-
UNSUS rats, but not in the NAc of APO-SUS rats. In contrast, cocaine 
increases the TH innervation of the mPFC of APO-SUS rats, but decreases 
this in APO-UNSUS rats. These data again underline the importance of the 
dopaminergic system in determining individual differences in the sensitivity 
to drugs of abuse. 
 
Cellular mechanism of cocaine and amphetamine  
As already mentioned in Chapter 1, the cellular mechanism behind the 
action of cocaine and amphetamine are different. Whereas increases in 
dopamine levels following cocaine exposure are mainly dependent on 
dopamine from the vesicular reserpine-sensitive dopamine pool114,115,185, 
increases in dopamine levels following amphetamine are mainly dependent 
on dopamine from the cytosolic aMpT-sensitive dopamine pool143,144. In 
Chapter 5, we investigated the cellular mechanism underlying the effects of 
amphetamine on prepulse inhibition (PPI) in APO-SUS and APO-UNSUS 
rats. Indeed we found that, in APO-UNSUS rats, the effects of amphetamine 
 126
Chapter 7                                                                                Concluding remarks            
                                                                           
on PPI are fully dependent on dopamine from the aMpT-sensitive pool. 
However, this was not the case for APO-SUS rats. The effects of 
amphetamine in these rats were dependent on dopamine from both the 
aMpT-sensitive and the reserpine-sensitive pool and not on dopamine from 
either of the pools alone.  
At this point, these data cannot be easily explained. However, one might 
speculate that the rate of dopamine exchange between the two pools may 
provide an explanation for these data. Namely, if the rate of exchange were 
very rapid in APO-SUS rats, aMpT alone would not be very effective in 
blocking the amphetamine-induced disruption of PPI, since dopamine in this 
pool would be refilled by dopamine from the reserpine-sensitive pool. In this 
light, it becomes understandable that the combination of aMpT and reserpine 
is able to block the amphetamine-induced effects. It would be interesting to 
investigate whether this is indeed the case.  
An alternative explanation for the data of Chapter 5 could be the size of the 
reserpine-sensitive dopamine pool. If the reserpine-sensitive pool is larger in 
APO-SUS rats than in APO-UNSUS rats, dopamine in the aMpT-sensitive 
pool can be resupplied from the reserpine-sensitive pool after depletion by 
amphetamine. Thus, aMpT alone would not block the amphetamine-induced 
disruption of PPI in APO-SUS rats. In APO-UNSUS rats, the reserpine-
sensitive pool is too small to continue resupplying dopamine in the aMpT-
sensitive pool (see Fig 1.). Thus administration of aMpT alone can block the 
amphetamine-induced effects. This explanation would also fit in with the 
data from Chapter 6 (see below).  
As mentioned above, the effects of cocaine are known to be dependent on 
dopamine from the reserpine-sensitive dopamine pool. In Chapter 6 we 
investigated the effects of cocaine on PPI in APO-SUS and APO-UNSUS 
rats and demonstrated that APO-SUS rats are far more sensitive to cocaine 
than APO-UNSUS rats, an effect that was mediated by dopamine D2 
receptors. Originally, the idea behind this study was to investigate the 
possible differences in the cellular mechanism of cocaine between APO-SUS 
and APO-UNSUS rats. However, cocaine did not decrease PPI in APO-
UNSUS rats at all, thereby making it impossible to study the effects of 
aMpT and reserpine on the cocaine-induced effects on PPI in these rats. 
Thus, for this study PPI did not turn out to be a very good read-out 
 127
Chapter 7                                                                                Concluding remarks            
                                                                           
parameter and it would be interesting to conduct this study using another 
technique such as in vivo microdialysis or voltammetry. 
It is interesting that cocaine induces a strong decrease of PPI in APO-SUS 
rats. As also described in Chapter 6, several studies have found no effect of 
cocaine on PPI243,258. This is remarkable given the fact that extracellular 
dopamine levels are inversely coupled to PPI. It is likely (see above) that 
cocaine induces a larger dopamine increase in APO-SUS than in APO-
UNSUS rats, but it is not likely that cocaine does not increase dopamine in 
APO-UNSUS rats at all. It is known that relatively high increases in 
dopamine levels are required in order to disrupt PPI. For instance, doses of 
amphetamine that already have a pronounced effect on (locomotor) 
behaviour (0.5-1.0 mg/kg99,111) are without effect on PPI. PPI is usually 
disturbed after relatively high doses of amphetamine (2.0-5.0 mg/kg)97. In 
addition, it is known that equimolar doses of cocaine are not as effective in 
increasing dopamine transmission in the NAc as amphetamine258. This could 
explain the disability of cocaine to disrupt PPI.  
An explanation for the fact that cocaine decreases PPI in APO-SUS rats 
might be the size of the reserpine-sensitive dopamine pool, as hypothesized 
above. As mentioned earlier, cocaine primarily acts upon the reserpine-
sensitive dopamine pool and induces dopamine release from this pool (apart 
from its effects on dopamine reuptake). If this pool were indeed larger in 
APO-SUS rats than in APO-UNSUS rats, this would explain why APO-SUS 
rats are more sensitive to the effects of cocaine on PPI than APO-UNSUS 
rats (see Fig 1).   
The data from Chapter 5 and 6 together show that APO-SUS rats are 
somewhat more sensitive to amphetamine and far more sensitive to cocaine 
than APO-UNSUS rats. The fact that the cellular mechanism behind the 
effects of amphetamine are different between these rat lines may not only 
have relevance to schizophrenia, as described in Chapter 5, but also to 
addiction. It is possible that people who are more vulnerable to addiction 
have a different mechanism of dopamine release following exposure to a 
drug such as amphetamine, but also perhaps cocaine, than people who are 
less vulnerable.  
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Fig 1. Schematic representation of the possible intraneuronal differences 
between the reserpine-sensitive dopamine pool (res) and the aMpT-sensitive 
dopamine pool (aMpT) in amphetamine or cocaine treated APO-SUS and 
APO-UNSUS rats. 
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Concluding remarks and future perspectives 
The data from this thesis contribute to our knowledge of the underlying 
mechanisms in animals that differ in their sensitivity to drugs of abuse. 
However, one should be careful in making a link to addiction in humans. 
Although drug self-administration has been investigated and differed 
between APO-SUS and APO-UNSUS rats, one cannot speak of an “addicted 
rat”. From the self-administration studies236,238 it is clear that these animals 
are perhaps in the early stages of “addiction”, but the intake patterns of 
cocaine and alcohol are far from compulsive. Therefore, it would be 
interesting to see whether these rats, if they were given prolonged access to 
cocaine, show an intake pattern that is compulsive and continues even 
though aversive stimuli are presented241. In addition, relapse behaviour, 
which is a crucial problem in addicts, has also not yet been studied in these 
rats. A beginning has been made to study the effects of early adverse life 
events on the drug self-administration behaviour in these rats240. It would 
also be interesting to study these effects on the brain dopaminergic systems 
of APO-SUS and APO-UNSUS rats.  
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De centrale doelstelling van dit proefschrift was te onderzoeken welke 
neurobiologische eigenschappen zouden kunnen bijdragen aan de 
verschillende respons van APO-SUS en APO-UNSUS ratten op verslavende 
middelen. Om deze doelstelling te bereiken zijn zowel 
immunocytochemische als gedragsfarmacologische technieken toegepast. 
In Hoofdstuk 1 zijn algemene theorieën over het ontstaan van verslaving 
besproken en is de drie-hit-hypothese voor psychiatrische aandoeningen 
geïntroduceerd. Deze hypothese stelt dat psychiatrische aandoeningen 
ontstaan door een combinatie van genetische factoren, vroege 
omgevingsfactoren en late omgevingsfactoren. Hoewel humaan onderzoek 
van onschatbare waarde is voor ons begrip ten aanzien van het ontstaan van 
verslavingen zijn deze studies vaak correlationeel en kan er geen causaal 
verband worden gelegd tussen een enkele gebeurtenis/factor en het ontstaan 
van verslaving. Daarom is het zinvol een diermodel te gebruiken waarin 
deze factoren onderzocht kunnen worden. Na het bespreken van een aantal 
diermodellen worden de apomorfine-gevoelige (APO-SUS) apomorfine-
ongevoelige (APO-UNSUS) ratten geïntroduceerd als het diermodel dat in 
dit proefschrift gebruikt wordt voor het onderzoek naar de neurobiologische 
basis voor verschillen in verslavingsgevoeligheid. Ten slotte wordt de 
neurobiologie van verslaving besproken. 
In Hoofdstuk 2 hebben we de uitgebreidheid van het tyrosine hydroxylase 
(TH) immunoreactieve (IR) vezel netwerk (middels lijn-intersectie tellen) en 
de numerieke dichtheid van TH-IR varicositeiten in de nucleus accumbens 
(NAc) van naieve APO-SUS en APO-UNSUS ratten bestudeerd. In deze 
studie laten we zien dat APO-SUS ratten een uitgebreider TH-IR 
vezelnetwerk en een hogere numerieke dichtheid van TH-IR varicositeiten 
hebben in zowel de core als de shell subgebieden van de NAc dan APO-
UNSUS ratten. 
In Hoofdstuk 3 hebben we onze studie van Hoofdstuk 2 uitgebreid door de 
respons van het TH-IR vezelnetwerk en de dichtheid van TH-IR 
varicositeiten op de milde omgevingsstressor novelty (nieuwheid). Daarbij 
hebben we ook microdialyse gebruikt om de hoeveelheid dopamine afgifte 
in de NAc te meten na novelty. Allereerst hebben we laten zien dat, in 
overeenstemming met de gegevens van Hoofdstuk 2, APO-SUS ratten een 
uitgebreider vezelnetwerk en meer varicositeiten hebben in de NAc shell en 
core dan APO-UNSUS ratten. We hebben geen basale verschillen in 
dopamine afgifte gevonden tussen de rat lijnen. We hebben laten zien dat 
novelty de uitgebreidheid van het TH-IR vezelnetwerk verhoogde in APO-
SUS ratten, maar niet in APO-UNSUS ratten. Hiermee overeenstemmend 
hebben we ook gevonden dat de dopamine afgifte na novelty groter was in 
APO-SUS dan in APO-UNSUS ratten. 
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In Hoofdstuk 4 hebben we de respons van de TH-IR varicositeiten in 5 
verschillende subgebieden van de NAc shell en in de NAc core onderzocht 
in reactie op cocaïne toediening (2 keer met een 72-uurs interval, 10 mg/kg 
i.p.). We hebben deze respons ook onderzocht in de verschillende lagen van 
de infalimbische (IL) en prelimbische (PrL) gebieden van de mediale 
prefrontale cortex (mPFC). Daarbij hebben we ook het noradrenerge systeem 
bestudeerd in de mPFC, gebruik makend van antilichamen tegen dopamine-
beta-hydroxylase (DBH). Als laatste hebben we ook de TH-IR cellichamen 
in 4 subgebieden van het ventrale tegmentale gebied (VTA) en in het 
mediale en laterale gedeelte van de substantia nigra pars compacta (SNc) 
onderzocht. In al deze studies hebben we de TH-IR varicositeiten 
gekwantificeerd met behulp van Stereo Investigator software. 
Ten eerste hebben we onze gegevens van Hoofdstukken 2 en 3 gevalideerd, 
namelijk dat de numerieke dichtheid van de TH-IR varicositeiten in alle 
subgebieden van de NAc groter was in APO-SUS dan in APO-UNSUS 
ratten. In de mPFC was de dichtheid alleen verschillend in IL laag 1, waar 
APO-UNSUS ratten een grotere dichtheid van TH-IR varicositeiten hadden 
dan APO-SUS ratten. Er zijn geen verschillen gevonden in de dichtheid van 
DBH-IR varicositeiten tussen de rat lijnen. APO-UNSUS ratten hadden een 
hogere dichtheid TH-IR cellichamen in het parabrachiale gedeelte van de 
VTA en in het mediale gedeelte van de SNc dan APO-SUS ratten. 
Behandeling met cocaïne verhoogde de dichtheid TH-IR varicositeiten in 
delen van de VTA en SNc in zowel APO-SUS als APO-UNSUS ratten. De 
reactie in het dopaminerge eindigingsgebied was echter verschillend tussen 
de rat lijnen. Terwijl cocaïne de dichtheid TH-IR varicositeiten verhoogde in 
bijna alle subgebieden van de NAc in APO-UNSUS ratten, had het geen 
enkel effect op deze parameter in APO-SUS ratten. In gedeelten van de 
mPFC verhoogde cocaïne de dichtheid TH-IR varicositeiten in APO-SUS 
ratten, maar verlaagde dit in APO-UNSUS ratten. Er werden bijna geen 
effecten gevonden op DBH-IR varicositeiten. 
Deze studie laat duidelijk zien dat cocaïne lijnspecifieke effecten teweeg 
bracht op dichtheid TH-IR varicositeiten in de mPFC en NAc, terwijl het een 
vergelijkbaar effect teweeg bracht op de TH-IR cellichamen in de VTA en 
SNc. 
In Hoofdstuk 5 hebben we het cellulaire mechanisme bestudeerd dat ten 
grondslag ligt aan de effecten van amfetamine op prepuls inhibitie (PPI) in 
APO-SUS en APO-UNSUS ratten. Het is bekend dat binnen de 
presynaptische dopaminerge eindigingen ten minste 2 verschillende 
dopamine pools aanwezig zijn, namelijk de alfa-methyl-paratyrosine (aMpT) 
gevoelige dopamine pool en de reserpine-gevoelige dopamine pool. aMpT is 
een TH remmer, remt de dopamine synthese en maakt zo de nieuw 
gesynthetiseerde dopamine pool leeg. Reserpine is een remmer van de 
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vesiculaire monoamine transporter (VMAT), die verantwoordelijk is voor 
het transport van dopamine uit het cytosol in blaasjes en reserpine maakt dus 
de blaasjes leeg. Deze pools werken niet onafhankelijk van elkaar en een 
constante uitwisseling van dopamine tussen de pools is aanwezig. Echter, 
studies hebben laten zien dat lage doses amfetamine een dopamine afgifte 
induceren die met name afhankelijk is van dopamine uit de aMpT-gevoelige 
dopamine pool, en niet van dopamine uit de reserpine-gevoelige pool. We 
hebben dit onderzocht in APO-SUS en APO-UNSUS ratten, gebruik makend 
van PPI, omdat het bekend is dat dopamine afgifte en PPI omgekeerd 
evenredig aan elkaar gecorreleerd zijn. 
Ten eerste hebben we laten zien dat APO-SUS ratten enigszins gevoeliger 
zijn voor acute toediening van amfetamine dan APO-UNSUS ratten, omdat 
alle doses amfetamine de PPI verlaagden in APO-SUS ratten, maar alleen de 
hoogste doses amfetamine verlaagden de PPI in APO-UNSUS ratten.  
Ten tweede hebben we laten zien dat de effecten van amfetamine op de PPI 
dopaminerg zijn, in ieder geval in APO-SUS ratten. 
Ten derde hebben we laten zien dat de amfetamine-geïnduceerde verstoring 
van de PPI in APO-UNSUS ratten, maar niet in APO-SUS ratten, opgeheven 
kan worden door aMpT. Ten vierde hebben we aangetoond dat reserpine de 
amfetamine-geïnduceerde verstoring van de PPI in beide rat lijnen niet op 
kon heffen. Als laatste hebben we aangetoond dat de combinatie van aMpT 
en reserpine de amfetamine-geïnduceerde verstoring van de PPI in APO-
SUS ratten wel op kon heffen. 
Deze gegevens laten zien dat APO-SUS ratten iets gevoeliger zijn voor 
amfetamine dan APO-UNSUS ratten en dat het cellulaire mechanisme dat 
ten grondslag ligt aan de effecten van amfetamine op de PPI verschillend is 
tussen de rat lijnen. 
In Hoofdstuk 6 hebben we de acute respons van APO-SUS en APO-UNSUS 
ratten op cocaïne toediening onderzocht, opnieuw gebruik makend van PPI. 
We hebben aangetoond dat APO-SUS ratten veel gevoeliger zijn voor 
cocaïne dan APO-UNSUS ratten, omdat alle doses cocaïne de PPI in APO-
SUS ratten verlaagden, maar geen enkel effect hadden op de PPI van APO-
UNSUS ratten. We hebben ook laten zien dat het effect van cocaïne 
opgeheven kan worden door de dopamine D2-receptor antagonist 
remoxipride en door de alfa1-adrenoceptor antagonist prazosine, maar niet 
door de serotonine 5HT2-receptor antagonist ketanserine.  
In Hoofdstuk 7 wordt een samenvatting van de data gegeven en worden 
enkele punten bediscussieerd. 
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voor het ondersteunen bij het uitvoeren van experimenten als om mijn 
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maar uiteindelijk konden we toch altijd een compromis vinden! 
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zoals het moest lopen. 
Jos, jij ook bedankt voor je hulp de afgelopen jaren, vooral ook met het 
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kwestie, maar jij hebt me er doorheen gesleept!!  
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Zo, en nu is het klaar! 
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